검색 전체 메뉴
맨 위로
OA 학술지
Potential of some traditionally used edible plants for prevention and cure of diabesity associated comorbidities
  • 비영리 CC BY-NC
  • 비영리 CC BY-NC
Potential of some traditionally used edible plants for prevention and cure of diabesity associated comorbidities
Ayurveda , diabesity , neurological disorders , Brassica juncea , Emblica officinalis , Piper longum , Curcuma

    Classical Ayurvedic texts are the oldest known ones pointing out that overweight, obesity, and diabetes are closely related lifestyle disorders, and that appropriate food choices and eating habits are necessary not only for proper maintenance of physical and mental health, but also for obtaining optimal therapeutic benefits from medicines and other health care measures (Rastogi, 2014; Sharma and Chandola, 2011a; Sharma and Chandola, 2011b). Modern nutritional and other researchers have now also well recognized that diverse phytochemicals commonly consumed with everyday meals have beneficial effects against overweight or malnutrition associated metabolic disorders encountered in patients suffering from, or at risk to diabetes, hyperlipidemia, and numerous others chronic diseases (Dembinska-Kiec et al., 2008; Farooqui, 2013; Gonzalez-Castejon and Rodriguez-Casado, 2011; Manach et al., 2009). Consequently, regular consumption of fruits, vegetables and other plant derived products are now highly recommended for reducing the risks of almost all such life threatening and silently progressing diseases (Anonymous, 2003; Agrawal et al., 2014). Despite extensive efforts and considerable progress (Janero, 2014; Kar and Roy, 2012; Singh et al., 2014a), prevention and cure of such disorders still continue to be a major challenge for both traditionally known as well as modern systems of medicine

    Epidemiological, preclinical, and some clinical evidences now available on numerous edible plants strongly suggest though, that their modulating effects on psycho-biological processes involved pathogenesis and progression of lifestyle associated medical conditions are involved in their traditionally known health benefits (Dembinska-Kiec et al., 2008; Gonzalez-Castejon and Rodriguez-Casado, 2011; Baboota et al., 2013; Chandrasekaran et al., 2012; Chang et al., 2013a; Tiwari and Rao, 2002). It is now also well recognised that structurally and functionally diverse secondary plant metabolites are biosynthesized by them for defending themselves against environmental stress (Kwon et al., 2009), and that their traditionally known health benefits are most probably due to their modulating effects on environmental and metabolic stress triggered psychobiological processes involved in pathogenesis and progression of chronic diseases (Calabrese et al., 2012; Kennedy, 2014a). Dysregulation of these processes often leads to diverse spectrums of pathologies including obesity and diabetes and other silently progressing metabolic and inflammatory disorders (Cnop et al., 2012; Ozcan et al., 2004; Zhao and Ackerman, 2006). Amongst them, diabesity, i.e. obesity triggered type-2 diabetes, is the most rapidly spreading global epidemic of the 21st century now affecting all countries irrespective of their socioeconomic status and cultural background (Farag and Gaballa, 2011). The only currently available interventions with curative potentials against diabesity are bariatric surgeries (Kahn et al., 2014; Tschop and DiMarchi, 2012), and it is now well recognized that dietary therapies in combination with some antidiabetic or anti-hyperglycemic drugs (especially metformin) and physical exercise are the most effective means for preventing progression of diabesity associated physical and mental health problems (Colagiuri, 2010; Pratley and Matfin, 2007). However, due to socioeconomic, cultural, and diverse other reasons, such therapeutic possibilities and recommendations are either not available, or are not affordable and acceptable, in many economically developing and underdeveloped countries where the burden of diabesity is the utmost (Pan et al., 1997; Ramachandran et al., 2006; Ramachandran et al., 2012).

    Culinary uses of numerous edible plants used in Ayurvedic and other traditionally system of medicine and health care are very popular in all such countries, and irrespective of their socioeconomic and cultural backgrounds, herbal therapies are the most affordable and acceptable health care options for a vast majority of population in most of them. Therefore efforts are now being made in many laboratories to identify edible and other plants with anti-hyperglycemic, anti-inflammatory, insulin sensitivity improving and other diabesity associated pathologies (Eddouks et al., 2014; Chang et al., 2013b; Leiherer et al., 2013). A consistent observation made with diverse types of extracts of numerous such edible and other plants in animal behavioral models has been that their stress response regulating and other efficacies increase with increasing number of days of treatments (Chatterjee and Kumar, 2012; Kumar and Chatterjee, 2014a). These and numerous other observations made during efforts to define pharmacological activity profiles of several such extracts strongly suggest that biological mechanisms and processes involved in antihyperglycemic or anti-diabetic efficacies of edible plants could as well be due to their stress response modulating effects, and that structurally diverse secondary plant metabolites ubiquitously encountered in many, if not most, edible and other plants are also involved in their such efficacies (Langstieh et al., 2014; Shivavedi et al., 2014a; Shivavedi et al., 2014b; Rauniyar et al., 2015; Verma et al., 2015; Shakya et al., 2015). In this communication, available preclinical and clinical information on a few Ayurvedic edible plants justifying these inferences are summarized and critically analyzed and discussed in light of our current understanding on stress response regulating potentials of edible and other phytochemicals.

    Brassica juncea (Mustard)

    Commonly known as oriental or brown or Indian mustard, Brassica juncea L. is one of the numerous edible plants of the Brassicaceae family now widely used in India and other countries for obtaining mustard seeds and edible oil. It is a draught resistant plant (also often considered as weed by agricultural industries) widely cultivated for meeting the great commercial demand of mustard seeds and oil with nutty taste and pungent aroma. Its green leaves (commonly called mustard green) are also often used as spicy vegetables, salad, and pickled condiment in many Asiatic countries. Medicinal uses of diverse varieties of mustard plants are mentioned in classical Ayurvedic texts, and Brassica juncea is one of the several plants of the family mentioned in such texts (Manohar et al., 2009). Nutritive values of mustard green and diverse medicinal and health care potentials of mustard seeds and oils have been known since long not only in India, but also in numerous other countries. Although nutritive values of edible green leaves of Brassica juncea have also been mentioned in classical Ayurvedic texts, they are seldom used in Ayurvedic pharmaceutical formulations.

    Information now available on medicinal phytochemistry of Brassica juncea leaves reveal though, that numerous bioactive phytochemicals encountered in them are either structurally identical or functionally similar to those identified in not only in different varieties mustard seeds, but also in many other pharmacologically and clinically better scrutinized edible plants of the Brassicaceae family. Amongst oil producing plants of this family, Brassica juncea is currently one of the major mustard oil producing crops in India, which is one of the major vegetable oils commonly consumed in the country (Mishra and Manchanda, 2012; Singh et al., 2014b). It has been suggested that regular consumption of mustard oil together with vegetarian diet could be a feasible dietary means for lowering the risk of ischemic heart diseases in Indian population (Rastogi et al., 2004). Since bitter and pungent taste of mustard oil and all condeiments and vegetables prepared from plants of the Braceacea family are not always well accepted by many consumers (Drewnowski and Gomez-Carneros, 2000), they are often not regularly consumed, or are well accepted, for culinary purposess by many consumers. Therefore, efforts are now being made by food and agricultural industries to obtain Brassica juncea products devoid of such tastes (Sindhu et al., 2012).

    Another reason for obtaining different cultivars of Brassica juncea is to obtain mustard oil with lower contents of Eruic acid, i.e an omega-9 fatty acids which has been reported to possess adverse health effects (Singh et al., 2013). Since potential adverse health effects of eucric acid (Sauer and Kramer, 1983; Choudhary et al., 2014), and also those of the pungent and bitter tasting isothiocyanate and other phytochemicals encountered in Brassica juncea derived products (Tripathi and Mishra, 2007; Inyang et al., 2014) have been observed in some animal bioassays, health care authorities of several countries have issued warnings against, or have even banned, edible uses of mustard oils (Oram et al., 2005; Wendlinger et al., 2014). However, as yet no very definitive statements based on preclinical, or clinical, or epidemiological evidence on maximally tolerated daily oral doses of such acids and numerous other phytochemicals commonly consumed with diverse types of mustard derived products can be made. This is mainly because appropriate dose response and other studies necessary for estimating their pharmacologically interesting dose ranges, safety profiles, and possible interactions between them are still missing.

    On the other hand, the numbers of reports suggesting potential health benefits of diverse types of Brassica juncea leaf and seed extracts and their bioactive constituents have continued to increase during recent decades (Kumar et al., 2011a). Apart from vitamins, minerals, and nutritive proteins and lipids, the plant is now well recognized to be a rich source of a numerous phytochemicals often encountered in diverse other edible plants and well known for their cellular stress response modulating and hormetic effects (Birringer, 2011; Calabrese, 2010; Calabrese et al., 2010). However, since in Ayurvedic system of medicine mustard derived products are always used in combination with other natural products and health care procedures, therapeutic relevance of these findings in their traditionally known medicinal uses still remain questionable or speculative only.

    The most extensively studied bitter and pungent tasting secondary metabolites encountered in Brassica juncea are the glucosinolates. Glucobrassicin, neoglucobrassicin, 4-methoxy glucobrassin and 4-hydroxy glucobrassicin are some indole glucosinolates more often encountered in Brassica juncea than in other plants of the family (Schreiner et al., 2009).

    Quantitatively though, sinigrin is one of the major glucosinolate encountered in Indian mustard (Sang et al., 1984), which is now often considered to be a bioactive secondary metabolite of several edible plants with anti-cancer and anti-microbial activities (Patel et al., 2012). During processing of mustard seeds glucosinolates are enzymaticaly degraded to allyl-isothiocyanate, which possesses strong bactericidal activities. Therefore, mustard meal powders are often recommended as a natural antimicrobial agent (Munday and Munday, 2002; Dai and Lim, 2014). Structurally diverse glucosinolates are also well known for their preventive potentials against cancer and other chronic diseases, including diabetic neuropathy and neurodegenerative diseases (Halkier and Gershenzon, 2006; Fahey et al., 2003; Tarozzi et al., 2013; Dinkova-Kostova and Kostov, 2012)

    Essential oils of Brassica juncea consists mainly of a group of structurally analogous isothiocyanates. Some of them, also found in edible mustard oil, are allyl isothiocyanate, diallyl trisulfide, 3-butenyl isothiocyanate, allyl isothiocyanate, diallyl trisulfide and 3-butenyl isothiocyanate (Yu et al., 2003). It has been estimated that such oils consists of ca. 11% saturated and 89% unsaturated fatty acid of which about 18% is linoleic and 15% is linolenic fatty acid (Mishra and Manchanda, 2012). Other fatty acids found in Brassica juncea are erucic, eicosanoic, arachidic, nonadecanoic, behenic, oleic and palmitic acids, and arachidonic and α-linolenic acids are also been encounter in its oils (Kumar et al., 2011a). Brassicasterol, campesterol, β-sitosterol, Δ5-avenasterol and trace amounts of Δ7-stigmasterol have also been isolated and characterized from the mustard seed oil (Li et al., 2000).

    Plant polyphenolics encountered in Brassica juncea, and in numerous other edible plants now attracting major attention of modern nutritionists and herbal researchers (Wang et al., 2014; Xiao and Hogger, 2015; Pandey and Rizvi, 2009). These are structurally diverse polyphenolic acids, quercetin, kaempferol, isorhamnetin and their naturally occurring conjugates, derivatives, and analogues (Cartea et al., 2010; Kumar and Andy, 2012; Kumar et al., 2012). Sinapic acid and its conjugates are quantitatively the major polyphenolics of Brassica juncea and it has been reported that it is one of richest natural sources of the acid and its conjugates (Niciforovic and Abramovic, 2014). Like for diverse other polyphenolic of Brassica juncea leaves, sinapic acid has also been identified as an antidiabetic agent with stress response modulating and antidepressant, anxiolytic and other brain function modulating activities (Cherng et al., 2013; Yoon et al., 2007).

    Isorhamnetin is also another Brassica juncea specific and quantitatively major flavonid of mustard green with an analogous broad spectrum of therapeutically interesting bioactivity profile. Although numerous flavonoid glycosides with oxidative stress protecting activities have been isolated from Brassica juncea Leaves (Jung et al., 2009; Kim et al., 2002), isorhamnetin glycosides have been reported to be their major antidiabetic component with such activities (Yokozawa et al., 2002; Yokozawa et al., 2003). A comparative study on flavonoid contents of 91 vegetables has revealed an unique flavonol aglycone spectrum in mustard green, and found that it has the highest amount isorhamnetin amongst all vegetables analyzed in that study (Yang et al., 2013). It must be mentioned though, that isorhamnetin and its conjugates are also human metabolites of quercetin and other naturally more abundant flavonoids (Manach et al., 2004). However, like for all other plant extracts, the pharmacological activity profiles, or antidiabetic activity, of Brassica juncea leaf extracts cannot be predicted from their contents of phenolic plant metabolites, or by their antioxidative potentials, only (Thakur et al., 2013a; Thakur et al., 2013b; Thakur et al., 2014a).

    Information now available on preclinical pharmacology of diverse types of extracts, and some of their often discussed bioactive constituents, suggesting their preventive and curative potentials against obesity and diabetes associated comorbidities are summarized in Tables 1 and 2 respectively. These and numerous other therapeutic possibilities offered by Brassica juncea and its bioactive secondary metabolites strongly suggest that modulation or regulation of psychological and metabolic stress triggered biological processes involved in etiology, pathogenesis, and progression of diverse lifestyle associated medical conditions and accelerated aging (Dietrich and Horvath, 2012; Epel, 2009; Fontana, 2009) are involved in their modes of actions. Consequently, efforts are now being made in several laboratories, including ours, to identify stress response modulating secondary metabolites of the plant, necessary for obtaining more rationally standardized extracts of the plant suitable for further developments as phyto-pharmaceuticals, or nutraceuticals, against diabesity and other lifestyle and environmental stress triggered mental health problems.

    [Table 1.] Pharmacological activities of diverse types of Brassica juncea extracts suggesting their curative or preventive potentials against diabesity associated comorbidities


    Pharmacological activities of diverse types of Brassica juncea extracts suggesting their curative or preventive potentials against diabesity associated comorbidities

    [Table 2.] Some major bioactive constituents of Brassica juncea identified to date, and their often-cited pharmacological activities


    Some major bioactive constituents of Brassica juncea identified to date, and their often-cited pharmacological activities

    For such purposes, or for dietary therapy with Brassica juncea derived food, it is necessary to cultivate, harvest and process the appropriate variety or strain of the plant. This is not only because the content of bioactive secondary metabolites of the plant vary considerably in different strains and cultivars of the plant, but also due to the fact that it is an accumulator of toxic metals like lead, arsenic, cadmium etc. (John et al., 2009; Podar et al., 2004; Jakovljevic et al., 2013). Blood levels of such metals in diabetic patients are often fairly high (Akinloye et al., 2013; Kuo et al., 2013; Afridi et al., 2008), and their adverse effect potentials are well known. This is another reason behind the efforts of agricultural and food industries, and researchers to identify Brassica juncea cultivar strains and cultivation conditions for increasing crop yields with lower heavy metal contents. Although some strains of the plant with high crop yields have been identified, many questions concerning their contents of healthy or unhealthy substances still remain to be solved.

    Such questions can be more rationally answered by collaborative efforts of medicinal phytochemists, herbal pharmacologists and toxicologists only. Availability of a convenient and well validated bioassays for identifying not only the therapy relevant secondary metabolites of the plant, but also for quantifying potential synergistic, antagonistic, additive effects between them is an essential prerequisite for such purposes. Since numerous known bioactive secondary metabolites of Brassica juncea and almost all edible medicinal plants possess physiological stress response regulating activity (Barrajon-Catalan et al., 2014; Joven et al., 2013; Lee et al., 2014; Tomas-Menor et al., 2015), it now apparent that traditionally known medicinal uses of mustards and other edible plants derived products in Ayurvedic system of medicine and health care is mainly due the presence of specific combinations of such substances in Ayurvedic formulations or in Ayurvedic vegetarian food menus. Therefore, it can safely be suggested that the now well validated mouse bioassay evolving from efforts to identify and pharmacologically characterize the stress response regulating constituents of Brassica juncea and other edible plants (Langstieh et al., 2014) could be an useful one not only for better understanding of Ayurvedic pharmacology, but also for discovering and developing urgently needed novel preventive and curative pharmaco-therapies against diabesity and other lifestyle associated physical and mental health problems.

    Piper longum

    Piper longum L., commonly known as Pippali or “Indian long pepper”, is a wildly growing and flowering perennial climber belonging to edible plants of Piperaceae family. It is now cultivated also for its fruits, which are usually dried and used as a spice and seasonings. Piper longum fruits have a similar, but somewhat hotter or more pungent taste than its close relative Piper nigrum, from which black, green and white pepper is obtained. The oldest known references of Piper longum come from ancient Ayurvedic texts where diverse medicinal and dietary uses of different parts of the plant are described (Manoj et al., 2004). In traditionally known Chinese system of medicine, the fruits are often used for treatments of hyperlipidemia, and during recent years, at least four structurally diverse anti-hyperlipidemic constituents, i.e. piperine, piperlongumine, pipernonaline, and 7, 4’-dimethyl ether of apigenin, have been identified from the fruits. According to these reports (Jin et al., 2009; Krishna et al., 2014), anti-hyperlipidemic efficacies of some of these Piper longum constituents in animal models are comparable to the currently widely used antihyperlipidemic drug simvastatin. However, the numbers of phytochemicals isolated from different parts of Piper longum, and their diverse bioactivities suggesting preventive and curative potentials of the plants against diverse malnutrition and other environmentally triggered inflammatory pathologies are not necessarily limited to these molecules only (Kumar et al., 2011b; Zaveri et al., 2010).

    Reports on structurally and functionally novel secondary metabolites of the plant as well as their novel therapeutically interesting and other bioactivities, or of their since long known secondary metabolites, have continue to appear during recent years (Yang et al., 2013; Ahmed et al., 2014; Huang et al., 2010; Jiang et al., 2013; Ku et al., 2014; Yang et al., 2014, Yadav et al., 2014). Apart from proteins, carbohydrates, starch, and other nutritive constituents, and volatilile oils, most known bioactive molecules isolated from different parts of the plant are often structurally classified as alkaloids (alkaloidal amides), saponines, lignans, and phenolics etc. However, none of them are very specific biomarkers of the plant, and all of them have also been isolated from other edible plants of Piperacea and other families. Some of the numerous alkaloids or alkaloidal amides encontered in Piper longum fruits are: piperine, methyl piperine, iperonaline, piperettine, asarinine, pellitorine, piperun decalidine, piperlongumine, piperlonguminine, refractomide A, pregumidiene, brachystamide, brachystamide-A, brachystine, pipercide, piperderidine, longamide and tetrahydropiperine, terahydro piperlongumine, dehydropipernonaline piperidine, piperine, terahydropiperlongumine and trimethoxy cinnamoyl-piperidine and piperlongumine (Zaveri et al., 2010). Piperine is often considered to be quantitatively the major (ca. 3 - 5% on dry weight basis) bioactive constituent of long pepper and it is also the major pungent tasting secondary metabolite of the plant. Therefore, it is now often used as a biomarker for analytically standardizing Piper longum extracts for experimental as well as commercial purposes.

    Pungency of piperine is caused by activation of the heat and acidity sensing ion channel TRPV1 on pain sensing nerve cells (McNamara et al., 2005). Such capsaicin like effects of piperine and other pungent alkaloidal amides of Piper longum are most probably also involved in pain response modulating effects of its diverse types of extracts. Altered pain sensitivity is a cardinal symptom of diabetic neuropathy and other inflammatory disorders, and crucial role of TRPV1 channel in etiology, pathogenesis, and progression of diabesity associated pathologies are now well recognized (Suri and Szallasi, 2008). However, the questions concerning the involvement of these ion channels in pain response regulating functions of brain or in observed mental function regulating effects of Piper longum and other herbal extracts, cannot yet be answered with certainty (Gunthorpe and Szallasi, 2008). It remains certain though, that piperine and other alkaloidal amides with pungent and spicy tastes are modulators of the functions of TPRV1 channel (Rios and Olivo, 2014) and that as a desensitizer of this channel piperine is more efficacious than capsaicin (Szallasi, 2005).

    Another bioactivity of piperine now attracting major attention of modern researchers is its ability to enhance bioavailability of other nutrients and drugs (Patil et al., 2011). Similar or analogous effects are also known for numerous other edible phytochemicals commonly consumed with every day meals (Muttepawar et al., 2014; Tatiraju et al., 2013). Although as yet no very definitive statements on biological mechanisms and process involved in such effects of piperine can be made, it remains certain that its regular consumption can enhance oral bioavailability of other essential nutrients and edible phytochemicals commonly consumed with everyday meals, or with phyto-pharmaceuticals and nutraceuticals. It has been reported, indeed, that piperine enhances oral bioavailability of the edible antidiabetic phytochemical curcumin by 2000% in human (Shoba et al., 1998), which is the quantitatively major bioactive constituent of another Ayurvedic herb Curcuma longa (to be described later). These and numerous other analogous observations made with piperine and other edible phytochemicals strongly suggest that modulations of bioavailability of essential nutrients are also involved in their observed beneficial effects on metabolic disorders, and that proper understanding of their Ayurvedic pharmacology and medicinal values is possible only when due attention is paid to their such properties.

    Another major alkaloidal amide encountered in Piper longum and attracting major attention of modern drug discoverers is piperlongumine, or piplartin (Bezerra et al., 2013). It is not encountered in Piper nigrum, the fruits of which are the most commonly consumed spice in the western world and elsewhere (Bezerra et al., 2013). Preclinical information now available on piplartin strongly suggest that it is most probably also one of the major bioactive secondary plant metabolites involved in diverse therapeutically interesting mental and metabolic function modulating effects of Piper longum fruits and roots (Bezerra et al., 2013), and that it could be a promising cancer therapeutic lead as well (Wu et al., 2014). Although piperlongumine and piperine are the two quantitatively the major bioactive constituents of numerous piper species commonly used in numerous Ayurvedic formulations (Meghwal and Goswami, 2013), their quantities vary considerable not only in different piper species but also in different parts of Piper longum and other plants of the species (Bao et al., 2014; Chandra et al., 2014).

    Piplartin was first isolated from Piper longum roots, dried powder of which are also often used by Ayurvedic and other practitioners of herbal medicine for treatments of insomnia and debility caused by chronic fever (Murthy, 2009), and diverse types of extracts of the roots and their combinations with other herbal extracts are now also commercialized in India as Ayurvedic remedies (Rajopadhye et al., 2012). Such remedies are often used for treatment of rheumatism and other inflammatory conditions, and aqueous suspension of powdered roots of Piper longum root, commonly called Pippalimula in India, has been reported to possess ibuprofen like analgesic activity (Vedhanayaki et al., 2003). During recent years, several reports revealing antidiabetic activities of aqueous and ethanolic extracts of Piper longum roots have also appeared (Chaurasia and Das, 2013; Chaurasia et al., 2012; Nabi et al., 2013). Extensive psycho-pharmacological and some clinical observations made in our Banaras Hindu University’s Ayurvedic hospital with Piper longum root powder have not only revealed its broad spectrum of therapeutically interesting neuronal function modulating activities, but also indicated that metabolic as well as psychological stress response modulating effects are also involved in its modes of actions. Since stress response regulating properties of a Piper longum fruits containing Ayurvedic formulation has been reported (Neha and Mishra, 2011), and several bioactive phytochemicals encountered in the roots and fruits used in the formulation are the same, it could as well be that the reported antidiabetic activity of the root extracts are also due to the presence of stress response regulating components in them.

    Major therapeutically interesting bioactivities of diverse types of Piper longum extracts and their quantitatively major bioactive constituents indicating therapeutic potentials of the plant for prevention and cure of obesity associated comorbidities are summarized in Tables 3 and 4 respectively. Although several recent reports have already revealed anti-obesity activity of piperine containing Piper longum oil in animal models (BrahmaNaidu et al., 2014; Choi et al., 2013; Doucette et al., 2013; Kumar et al., 2013; Noble et al., 2013), many questions concernig the roles of other bioactive constituents in such oils still remain open. Moreover, many such reports pay little attention to the fact that piperine and other constituents of such oils also possesses mental function regulating activities (Cicero Bezerra Felipe et al., 2007; Gilhotra and Dhingra, 2014; Li et al., 2007a; Li et al., 2007b; Mao et al., 2014; Pal et al., 2011), and that their modulating effects on central nervous system could as well be involved in anti-obesity and other health benefits of Piper longum derived products against type-2 diabetes (Sandoval et al., 2009; Patrone et al., 2014; Banks et al., 2012). It cannot be ignored though, that due to very hot taste of such products, they might not be well suited for incorporating them in everyday meals in high enough quantities necessary for obtaining health benefits from them.

    [Table 3.] Some reports suggesting therapeutic potentials of Piper longum extracts against diabesity and associated comorbidities


    Some reports suggesting therapeutic potentials of Piper longum extracts against diabesity and associated comorbidities

    [Table 4.] Major bioactive constituents of Piper longum L. identified to date, and their often-cited pharmacological activities


    Major bioactive constituents of Piper longum L. identified to date, and their often-cited pharmacological activities

    Amlaki and Triphala

    Amlaki is the Sanskrit name of the edible fruits of Phyllanthus emblica (synonym: Emblica officinalis; common name: Indian gooseberry) most commonly used in Ayurvedic system of medicine and health care as a tonic and for prevention and cure of physical as well as mental health problems arising from intricate disorders of digestive and excretory organs. It is also one of the most widely used edible fruits in numerous Ayurvedic formulations. One such very popular formulation is Triphala, which consists of equal parts of dried edible fruits of Embelica officinalis, Terminalia chebula, and Terminalia bellirica (Belapurkar et al., 2014; Maheshwari and Rajnee, 2014). Preventive and curative use of both Amlaki as well as of Triphala with barley and other dietary measures for treatments of diabetes is recommended in ancient Ayurvedic texts, and their such medicinal uses are now well justified by numerous preclinical and some therapeutic observations reported during recent decades (Sharma and Chandola, 2011a; Sharma and Chandola, 2011b; D’Souza et al., 2014; Mohammad and Larijani, 2013; Tiwari, 2008; Rajan and Antony, 2008). In classical Ayurvedic texts numerous other formulations containing them are mentioned also (Chulet and Pradhan, 2009; Chouhan et al., 2013), and in traditionally known Indian, Chinese, and Arabic systems of medicine Triphala is more often than not used in combination with other medicinal herbal herbs and other health care practices (Mohammad and Larijani, 2013; Zaki et al., 2014). Amongst the three edible fruits constituting Triphala formulations, the one most widely harvested and consumed for culinary purposes is Amlaki.

    Recent neuropsychopharmacological observations (Kumar and Chatterjee, 2014b; Dhanalakshmi et al., 2007; Dhanalakshmi et al., 2006; Nariya et al., 2011; Rinki and Mishra, 2011; Srikumar et al., 2006) have revealed a broad spectrum of neuronal function modulating effects of Triphala, and suggest that its modulatory effects against glucose toxicity and diverse metabolic or mental stress triggered biological responses could be involved in its modes of actions. It is a sour, bitter, and astringent tasting fruit, which is often steeped in salt water and turmeric to make the sour fruits palatable. Gallic and Elegiac acids and their conjugates are some of the quantitatively major bioactive constituents of all the three fruits composing Triphala (Patel and Shah, 2009). However, the spectrum of known bioactive secondary plant metabolites encountered in Amlaki is not identical to those known for the other two fruits commonly used in this and numerous other Ayurvedic formulation. Available information on the bioactive constituents, and experimental evidences suggesting therapeutic potentials of Amlaki for treatments of diabesity and diverse other diseases have often been reviewed during recent years (D’Souza et al., 2014; Dasaroju and Gottumukkala, 2014; Khosla and Sharma, 2012; Krishnaveni and Mirunalini, 2010; Sri et al., 2013). Amlaki is also one of the several Ayurvedic medicinal herbs currently universally well recognized by modern herbalists and herbal researchers as an herbal adaptogen (Winston and Maimes, 2007). The concept of herbal adaptogens evolved originally in Russia during late 1940s (Brekhman and Dardymov, 1969), and the very first more systematic and detailed report on adaptogenic, or biological stress response regulating, effects of Amlaki and a few other edible and other Ayurvedic medicinal plant appeared in 1999 (Rege et al., 1999). Since then this concept has been well accepted by almost all modern scholars and practitioners of Ayurvedic system of medicine, and efforts are now being made by modern researchers to experimentally verify the efficacies of combinations of Amlaki with other edible plants and Ayurvedic therapeutic practices for prevention and cure of type-2 diabetes (Tripathi et al., 2012; Vaibhavi et al., 2013).

    One of the several Amlaki formulation specially recommended in classical Ayurvedic texts for treatment of diabetes-associated comorbidities is Nishamlaki, which consists of Amlaki and Turmeric rhizome (to be described later). They are also the two major constituents of a vast majority of herbal formulations currently commonly prescribed in India for treatments of diabesity (Sarma et al., 2014). Therefore, efforts are now being made to better standardize such a formulation that could eventually be more rationally developed and used for prevention and cure of diabetes (Rao et al., 2013; Venkateshwarlu et al., 2013). A recent report have revealed though, that inappropriate formulations or doses of such preparations could as well have adverse drug-drug interaction with metformin (Puranik et al., 2014), i.e. one of the main anti-diabetic drugs commonly recommended for treatments of type-2 diabetes. Efforts to answer the question whether Amlaki, or Turmeric, or inappropriate combinations of the two are involved in such herb-drug interaction will be necessary for more rational uses of the two edibles for prevention and cure of diabesity. Moreover, since both Amlaki as well turmeric are often consumed in India with every day meals, and both diabetes and obesity are also the most common metabolic disorders encountered in Indian, China, and other developing countries, efforts to better clarify the situation is urgently needed for obtaining appropriate medicinal benefits from metformin and other antidiabetic drugs in these countries (Neerati et al., 2012).

    Available information on medicinal phytochemistry of the other two fruits constituting Triphala strongly suggest that they could also have adverse herb-drug interactions with metformin and other drugs currently often prescribed for prevention and cure of diabesity associated physical and mental health problems (Fasinu et al., 2012). Although a few known bioactive secondary metabolites of Emblica officinalis (D’Souza et al., 2014; Khosla and Sharma, 2012; Zhang et al., 2001; Rastogi and Mehrotra, 1995; Asolkar et al., 1992; Dasaroju and Gottumukkala, 2014), are not encountered in Terminalia chebula (Rastogi and Mehrotra, 1995; Saleem et al., 2002; Kokate et al., 2003; Rathinamoorthy and Thilagavathi, 2014; Walia and Arora, 2013; Gupta, 2012) or in Terminalia bellirica (Saleem et al., 2002; Kokate et al., 2003; Kadian et al., 2014; Kumudhavalli et al., 2010; Saxena et al., 2013), all of them are fairly rich sources of tannins, gallic acids and their conjugates, and several other secondary plant metabolites ubiquitously present in many edible and other plants and well known for their modulating effects on drug metabolizing enzymes and their bioavailability (Serrano et al., 2009; Anannarukan et al., 2012). It has been reported that drug metabolizing enzyme inhibitory properties of Triphala are involved in such observed effects of the formulation, and that in this respect all the three constituents of the formulation are almost equipotent (Ponnusankar et al., 2011). According to this report, gallic acid and its conjugates and derivatives are also their common polyphenolic constituent involved in such effects of Triphala.

    It must be mentioned though, that gallic acid conjugates and other plant polyphenolics are also encountered in numerous other edible and medicinal plants, and that they are now well recognized for their protective effects against oxidative stress triggered pathologies, including diabetes and associated psychopathologies (Lee et al., 2014; Dragan et al., 2015; Khadem and Marles, 2010; Lephart, 2015; Liu et al., 2015; Santilli et al., 2015). Moreover, analgesic, anti-inflammatory, antidiabetic, anxiolytic, antidepressant, cognitive function modulating, antimicrobial, and diverse other therapeutically interesting bioactivities of diverse types of extracts of Amlaki and Triphala enriched in such phytochemicals also have often been reported. Detailed discussions and critical analysis of these reports dealing with their diverse such bioactivities is beyond the scope of this communication. For such purposes, the already cited references have to be consulted.

    It must be mentioned though, that numerous observations made with Amlaki, Triphala, and numerous other edible plant derived products have consistently revealed that their oral efficacies for stress responses modulating and other bioactivities increase with increasing numbers of treatment days (Kumar and Chatterjee, 2014a), and that this is most probably due to their modulating effects on microbial ecology inside the gastrointestinal tract (Thakur et al., 2014b). Although our current knowledge on the bactericidal constituents of Triphala and its constituents is far from being satisfactory, evidence now available on their diverse types of formulations strongly suggest that Gallic and Ellagic acids and their conjugates and soluble and insoluble polymers (commonly referred to as tannins) are their major secondary metabolites involved in bactericidal activities of their commercialized extracts (Biradar et al., 2008). It is now well recognized that gut microbial ecology plays a crucial role in the etiology, pathogenesis and progression of diabesity (Burcelin et al., 2011; Everard and Cani, 2013), and that such and other plant phenolics and their metabolites are regulators of gut microbial ecology (Bolca et al., 2013; van Duynhoven et al., 2011). Therefore, it is now apparent that proper understanding of their modulating effects on gut microbial ecology is an essential prerequisite for their more rational uses as dietary therapies against diabesity and associated mental health problems (Dinan and Cryan, 2012; Wang and Tang, 2015).

    Curcuma longa (Turmeric)

    Curcuma longa (synonym: Curcuma domestica and commonly called turmeric) is one of the several plants of the Zingiberaceae family (genus: curcuma), well known since antiquity to the scholars and practitioners of traditionally known systems of medicine for diverse health benefits of their rhizomes. It is now widely cultivated and diversely processed in India, China, and many other countries for obtaining dried roots and other products from them for culinary as well as medicinal purposes (Li et al., 2011). In Ayurvedic and other traditionally known Indian system of medicine, turmeric is now often used as a general tonic and blood purifier and also for prevention and cure of inflammatory diseases. Currently, it is phytochemicallly and pharmacologically one of the more extensively studied edible plant derived products of medicinal interest. Numerous reviews and monographs describing diverse therapeutic possibilities offered by the plant and its bioactive secondary metabolites have appeared during recent years (Chaudhary et al., 2010; Gupta et al., 2013; Chempakam and Parthasarathy, 2008). Available preclinical and clinical information on anti-diabetic potentials of the plant has also been summarized in a recent issue of this journal (Ponnusamy et al., 2012). Most such reviews and reports often neglect though, that modulating effects of curcumin and other turmeric curcuminoids on brain functions could as well be involved in their modes of actions and health benefits. Some of the reports suggesting such possibility for curcumin and two other Turmeric curcuminoids are summarized in Table 5.

    [Table 5.] Some reported neuro-pharmacological activities of Curcumin and of two other Turmeric curcuminoids


    Some reported neuro-pharmacological activities of Curcumin and of two other Turmeric curcuminoids

    Amongst numerous known bioactive and therapeutically interesting secondary metabolites of turmeric identified and quantified to date, the three structurally and functionally analogous ones with antioxidative properties, i.e. curcumin, desmethoxycurcumin, and bisdesmethoxycurcumine (often collectively referred to as curcuminoids), have attracted the most attention of modern herbal researchers and drug discoverers (Aggarwal et al., 2007; Ahmed and Gilani, 2014; Alappat and Awad, 2010; Bradford, 2013; Grynkiewicz and Slifirski, 2012; Jayaprakasha et al., 2006; Lopresti et al., 2014; Sahebkar, 2013). Hereupon, by far a vast majority of preclinical and clinical reports deal mainly on two major obesity associated medical conditions, i.e. diabetes and cancer (Zhang et al., 2013). These efforts have not only continued to add preclinical and clinical evidences suggesting their therapeutic potentials against these and diverse other malnutrition associated health problems, but also have leaded to better understanding of medicinal phytochemistry and molecular pharmacology of curcuminoids (Grynkiewicz and Slifirski, 2012; Priyadarsini, 2014; Brodniewicz and Grynkiewicz, 2012). Some reports suggesting therapeutic potentials of Curcuma longa extracts against diabesity and associated comorbidities are summarized in Tables 6.

    [Table 6.] Reports suggesting therapeutic potentials of Curcuma longa extracts against diabesity and associated comorbidities


    Reports suggesting therapeutic potentials of Curcuma longa extracts against diabesity and associated comorbidities

    However, curcumin and curcuminoids are not the only bioactive secondary metabolites of Curcuma longa potentially involved in diverse traditionally known, or recently identified therapeutic potentials of turmeric (Aggarwal et al., 2013; Bhanumathy et al., 2013; Kasabri et al., 2014; Lekshmi et al., 2012). Although the list of bioactive phytochemicals, vitamins, and other micronutrients commonly consumed with turmeric, and which could also be involved in traditionally known health benefits of the spice have consistently been enlarged during the past few decades (Wang et al., 2014; Mirmiran et al., 2014; Vaidya, 2014), many questions concerning oral bioavailability, and the doses and treatment regimen necessary for obtaining therapeutic benefits from curcuminoids, or for that matter for any of the till now known bioactive secondary metabolites of turmeric, cannot yet be answered with any certainty (Anand et al., 2007). Some observations made in vitro, suggest that oral bioavailability of curcuminoids from turmeric could as well be higher than those of pure curcuminoids (Maheshwari, 2010). However, therapeutic relevance of these observations still remains questionable. This is mainly because numerous metabolic and behavioral effects observed after daily oral doses of curcuminoids seldom correlate with their blood levels observed after their single or repeated daily oral doses. Such is specially the case for their stress triggered brain function modulating effects in experimental animals observed after their oral doses commonly used for assessing their therapeutic potentials against diabesity and other metabolic disorders (Xia et al., 2011; Xia et al., 2006).

    Taken together, these observations clearly suggest that health benefits of curcuminoids and other turmeric phytochemicals are either due to their bioactive metabolites, or that their observed broad spectrum of bioactivities are due to their non-systemic effects. Since turmeric is always consumed with other food ingredients containing diverse other bioactive molecules with broad spectrums of bioactivity profiles, it is almost certain that traditionally known health benefits of turmeric, cannot entirely be due to its curcuminoids contents, or on their blood levels observed after turmeric intake, only. Since analogous is the situation for almost all medicinally used edible plants and phytochemicals, attempts are now being made in several laboratories to use system-biology based pharmacological approaches for more rationally solving such problems (Goodacre, 2007; Nyanginja and Mponda, 2014; van Ommen and Stierum, 2002). However, during most such efforts attempts are made to better define the cellular and molecular mechanisms potentially involved in their modes of action, and as yet only very little attention has been paid to potential role of the so called microbiota-gut-brain axis in their observed effects in experimental animals and human volunteers and patients (Thakur et al., 2014b; Chiou et al., 2014; Greiner et al., 2014). However, the possibility that modulation of colonic microbiota could be involved in colon cancer prevention has recently been pointed out also (McFadden et al., 2014).

    Some major difficulties encountered during efforts to extrapolate preclinical findings made with turmeric extracts and their known bioactivities in terms of traditionally known medicinal uses of the turmeric arise also from the fact that depending on harvesting and processing procedures used for medicinal value and the contents of curcuminoids and other bioactive constituents vary considerably (Pal et al., 2008). A recently reported computer assisted study have revealed that at least 200 structurally and functionally diverse bioactive phytochemicals can be expected to be present in a given turmeric sample (Balaji and Chempakam, 2010), and that many of them have them have adverse effect potential as well. Results of this in silico study have revealed that out of the 200 compounds screened, 184 were predictably toxigenic, 136 mutagenic, 153 carcinogenic, and 64 hepatotoxic, and that only 16 of them are devoid of any of these adverse effects detectable by the in silico procedure used. Although this report supplies an exhaustive list of bioactive secondary metabolites of Curcuma longa, predictive validity of the observations reported there must be judged with caution (Balaji and Chempakam, 2010). Numerous toxicological and safety reports on diverse types of products derived from the plant have always pointed out that their adverse effect can be expected only after their extremely high daily oral doses that cannot be consumed with every day meals or with Ayurvedic formulations containing them (Chainani-Wu, 2003; Joshi et al., 2003; Lao et al., 2006; Madhu et al., 2013; Micucci et al., 2013; Qureshi et al., 1992; Ulbricht et al., 2011; Velusami et al., 2013; Liju et al., 2013; Hasan et al., 2014).

    Some high dose adverse effect potentials of phytochemicals often cited deal with their possible effect on liver functions (Kandarkar et al., 1998; Babu and Srinivasan, 1997), and those of gastrointestinal tract and skin (Fetrow and Avila, 1999). Unfortunately, as yet only a very few scattered reports on dose response studies necessary for predicting therapeutically interesting and safety margin of Curcuma longa extracts (other than those highly concentrated in curcumin and curcuminoids) have appeared (Micucci et al., 2013; Joshi et al., 2011). Results of one such recently reported preliminary study conducted in mice have revealed not only metformin (currently the drug of first choice for prevention and cure of diabesity) like stress response suppressing effects of fairly low daily oral doses of curcumin and some Curcuma longa extracts enriched in curcuminoids, but also suggest that even more than their 50 fold higher daily oral doses are fairly well tolerated by both male and female animals (Verma et al., 2015, Verma et al., 2014). Recent observations made in our laboratories with turmeric oil devoid of curcumin indicate that analogous is also the case for such oils (manuscript in preparation). These observations, and numerous other revealing that curcumin and diverse other turmeric constituents modulate the functions of stress responses mediated by shock proteins (Ali and Rattan, 2006; Speciale et al., 2011), add experimental evidences in support of the convictions that stress response regulating effects of turmeric derived products are involved in their modes of action, and that curcuminoids are not their only antidiabetic or stress response modulating bioactive constituents.

    Phytochemicals, stress and diabesity

    The term “diabesity” was initially coined during early 1970s to describe strong pathogenic links between obesity and type-2 diabetes (Sims et al., 1973). Although since then it has been well established that complex interactions between obesity, insulin resistance, and pancreatic ß-cell dysfunction cause type-2 diabetes, biological mechanisms and processes regulating the interplay among these impairments still remain to be better defined (Tschop and DiMarchi, 2012; Martinez and Milagro, 2015). However, it is now well recognized that even modest reduction of body weight can lead to significant improvements in glucose homeostasis of patients suffering from, or at risk to, diabesity (Martinez et al., 2014; Pati et al., 2014), and that uncontrollable stressful events and chronic stress states have significant and positive association with weight gains and type-2 diabesity (Adam and Epel, 2007; Dallman et al., 2005; Steptoe et al., 2014). This is most probably due to behavioral alterations triggered by environmental or mental stress, which eventually leads to addiction-like eating behavior (Ahmed et al., 2013; Ginty, 2013; Ginty et al., 2012; Scott and Johnstone, 2012; Sinha and Jastreboff, 2013). Although several questions concerning individual food components involved in “addictive eating behavior” still remain open (Ahmed et al., 2013; Davis, 2014; Meule et al., 2014), it is now almost certain that proper modulation of this behavior could indeed be an effective strategy for prevention of obesity associated physical and mental health problems (Meule et al., 2014; Murray et al., 2015; Pedram and Sun, 2015).

    Amongst structurally diverse secondary plant metabolites with stress response modulating and other therapeutically interesting bioactivities, polyphenolics have attracted the most attention of modern nutritional researchers and pharmacologists (Lee et al., 2014; Nowak, 2015; Pa and Gazzaley, 2014). Although their health benefits are often considered to be due to their antioxidative properties, like other diverse phytochemicals (edible or not), they also possess broad spectrums of bactericidal, anti-inflammatory, immune function modulating, and numerous other therapeutically interesting bioactivities (Kennedy, 2014a; Kennedy, 2014b). Mounting preclinical and clinical evidences accumulated during the past few decades strongly suggest that their modulating effects on gut microbial ecology and digestive functions are also involved in their modes of actions (Thakur et al., 2014b). It is now well recognized that metabolic and psychological stress responses also alter gut microbial ecology, which in turn alters the functions of the gut-brain axis (Aroniadis and Brandt, 2013; Mayer, 2011; Moloney et al., 2014). According to the postmodern eco-physiological and pharmacological concept arising from these findings (Abedon, 2014), circulating blood levels of edible phytochemicals observed after their oral intake must not necessarily be very reliable indicators of their brain function modulating effects. Available information on metabolic fate of numerous edible polyphenolics (van Duynhoven et al., 2011) is also in agreement with this inference.

    Eco-physiological and other studies have now established that secondary plant metabolites afford survival benefits to plants against enviorenmental stress (Kennedy, 2014a; Kennedy, 2014b; Trowbridge, 2014), and that structurally and functionally diverse edible phytochemicals possess pleiotropic protective effects against stress responses and are potentially useful for prevention and cure of diabetes, Alzheimer’s disease and other chronic silently progressing chronic diseases (Dembinska-Kiec et al., 2008; Leiherer et al., 2013; Davinelli et al., 2012; Vaiserman, 2014; Carriba and Comella, 2014; Franco and Cedazo-Minguez, 2014; Ruden and Lu, 2011). However, it has been also reported that depending on the components of whole-food some of them could as well worsen cognitive dysfunctions (Parrott et al., 2015). Available information on dose response relationship of numerous nutritive and other phytochemicals have revealed indeed that their protective or amplifying or adverse effects on stress responses depend on their daily doses and treatment regimen used, and that hereupon their beneficial effects often predominates (Calabrese et al., 2012; Le Bourg and Rattan, 2014; McClure et al., 2014). Such dose response relationships of bioactive molecules are due to their dose dependant modulating effects on diverse cellular adaptive stress responses (Birringer, 2011; Costantini et al., 2010) which often leads to their experimentally observed inverted U or J shaped dose response curves, or hormetic effects, in bioassays (Bao et al., 2014; Lushchak, 2014a). Evaluation of dynamics of such effects of edible phytochemicals are essential prerequisite for better understanding of their pharmacokinetic and pharmacodynamic properties necessary for obtaining health benefits offered by them (Lushchak, 2014b). This is because exposures to short term stress (hormetic stress) can strengthen subsequent response to stress, and prolonged stress exposures leads to toxic stress which shorten life span, and also leads to mental health problems (Lee et al., 2014; Epel and Lithgow, 2014; Scapagnini et al., 2014)


    The possibility that physiological or psychological stress is a major contributing factor to health problems triggered or caused by obesity and diabetes have often been pointed out during recent decades (Brindley and Rolland, 1989; Gastaldi and Ruiz, 2009; Kelly and Ismail, 2015). It is now well recognized also that the functions of all bodily or gas including those of the brain, and gut microbiota are altered by metabolic as well as mental and environmental stress (Steptoe et al., 2014; Carvalho et al., 2015; Cryan and Dinan, 2012; Foster and McVey Neufeld, 2013; Nicholson etal., 2012; Rhee et al., 2009). Although modern researchers have now well recognized that targeting the central nervous system is a promising approach for discovering drugs against obesity associated diabetes and other metabolic disorders (Sandoval et al., 2009; Lin and Sun, 2010; Perez-Tilve et al., 2012), most modern drug discoverers still continue to neglect that gut microbial ecology plays a crucial role in regulations of all bodily and mental functions (Baty et al., 2014; Triggle, 2012). Recent reports have pointed out though, that dietary phytochemicals are regulators of gut microbial ecology (D’Aversa et al., 2013), and that plant and other natural products libraries are valuable sources for identifying drug leads acting on proteins regulating stress responses (Davenport et al., 2014).

    As summarized in this communication, many edible plants traditionally known for their medicinal values are pleiotropic stress protective agents with anti-obesity, antidiabetic, antidepressant, anxiolytic, memory function modulating, analgesic and other brain function modulating activities. Diverse combinations of their secondary metabolites with demonstrated stress response regulating and broad spectrums of pharmacologically interesting bioactivity profiles are encountered in almost all terrestrial plants (medicinal, or not) as well. These findings not only justify their medicinal uses in Ayurvedic and other traditionally known systems of medicine and health care, but also strongly suggest that more holistic pharmacological strategies will be necessary for better understanding of therapeutic potentials of traditionally known medicinal plants, or for obtaining novel therapeutic leads from edible and other plant derived products containing edible phytochemicals. During such efforts due attention has to be paid not only to their stress response regulating and microbicidal properties, but also to the fact their adaptogenics like efficacies increases with increasing number of treatment days.

  • 1. Abedon ST 2014 Phage therapy: Eco-physiological pharmacology [Scientifica (Cairo)] Vol.2014 P.581639 google
  • 2. Abu-Taweel GM, Ajarem JS, Ahmad M 2013 Protective effect of curcumin on anxiety, learning behavior, neuromuscular activities, brain neurotransmitters and oxidative stress enzymes in cadmium intoxicated mice [J Behav Brain Sci] Vol.3 P.74-84 google cross ref
  • 3. Adam TC, Epel ES 2007 Stress, eating and the reward system [Physiol Behav] Vol.91 P.449-458 google cross ref
  • 4. Afridi HI, Kazi TG, Kazi N, Jamali MK, Arain MB, Jalbani N, Baig JA, Sarfraz RA 2008 Evaluation of status of toxic metals in biological samples of diabetes mellitus patients [Diabetes Res Clin Pract] Vol.80 P.280-288 google cross ref
  • 5. Agarwal NB, Jain S, Agarwal NK, Mediratta PK, Sharma KK 2011 Modulation of pentylenetetrazole-induced kindling and oxidative stress by curcumin in mice [Phytomedicine] Vol.18 P.756-759 google cross ref
  • 6. Aggarwal B, Sundaram C, Malani N, Ichikawa H 2007 The indian solid gold. In The molecular targets and therapeutic uses of curcumin in health and disease [Adv Exp Med Biol] Vol.595 P.1-75 google
  • 7. Aggarwal BB, Yuan W, Li S, Gupta SC 2013 Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric [Mol Nutr Food Res] Vol.57 P.1529-1542 google cross ref
  • 8. Agrawal S, Millett CJ, Dhillon PK, Subramanian SV, Ebrahim S 2014 Type of vegetarian diet, obesity and diabetes in adult indian population [Nutr J] Vol.13 P.89 google cross ref
  • 9. Ahmed B, Tripathi K, Pandey ND, Khan M 2014 Piperone-3 and piperone-4: Two new ketones isolated from Piper longum L. Dried fruits [Intl J Pharm Sci Rev Res] Vol.26 P.318-321 google
  • 10. Ahmed SH, Guillem K, Vandaele Y 2013 Sugar addiction: Pushing the drug-sugar analogy to the limit [Curr Opin Clin Nutr Metab Care] Vol.16 P.434-439 google cross ref
  • 11. Ahmed T, Gilani AH 2014 Therapeutic potential of turmeric in alzheimer’s disease: Curcumin or curcuminoids? [Phytother Res] Vol.28 P.517-525 google cross ref
  • 12. Akinloye O, Ogunleye K, Oguntibeju OO 2013 Cadmium, lead, arsenic and selenium levels in patients with type 2 diabetes mellitus [African J Biotechnol] Vol.9 P.5189-5195 google
  • 13. Alappat L, Awad AB 2010 Curcumin and obesity: Evidence and mechanisms [Nutr Rev] Vol.68 P.729-738 google cross ref
  • 14. Ali RE, Rattan SI 2006 Curcumin’s biphasic hormetic response on proteasome activity and heat-shock protein synthesis in human keratinocytes [Ann N Y Acad Sci] Vol.1067 P.394-399 google cross ref
  • 15. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB 2007 Bioavailability of curcumin: Problems and promises [Mol Pharm] Vol.4 P.807-818 google cross ref
  • 16. Anannarukan N, Niwattisaiwong N, Warisnoicharoen W, Winitthana T, Pramyothin P, Chaichantipyuth C, Lawanprasert S 2012 Inhibition of human cytochrome p450 in vitro by phyllanthus amarus and Phyllanthus emblica aqueous extracts [Thai J Pharm Sci] Vol.36 P.135-143 google
  • 17. 2003 Position of the american dietetic association and dietitians of canada: Vegetarian diets [J Am Diet Assoc] Vol.103 P.748-765 google cross ref
  • 18. Aroniadis OC, Brandt LJ 2013 Fecal microbiota transplantation: Past, present and future [Curr Opin Gastroenterol] Vol.29 P.79-84 google cross ref
  • 19. Asolkar LV, Kakkar KK, Chakre OJ 1992 Glossary of indian medicinal plants with active principles, second supplement google
  • 20. Baboota RK, Bishnoi M, Ambalam P, Kondepudi KK, Sarma SM, Boparai RK, Podili K 2013 Functional food ingredients for the management of obesity and associated co-morbidities - a review [J Funct Foods] Vol.5 P.997-1012 google cross ref
  • 21. Babu PS, Srinivasan K 1997 Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats [Mol Cell Biochem] Vol.166 P.169-175 google cross ref
  • 22. Balaji S, Chempakam B 2010 Toxicity prediction of compounds from turmeric (Curcuma longa l) [Food Chem Toxicol] Vol.48 P.2951-2959 google cross ref
  • 23. Banks WA, Owen JB, Erickson MA 2012 Insulin in the brain: There and back again [Pharmacol Ther] Vol.136 P.82-93 google cross ref
  • 24. Bao L, Bai S, Borijihan G 2012 Hypolipidemic effects of a new piperine derivative gb-n from Piper longum in high-fat diet-fed rats [Pharm Biol] Vol.50 P.962-967 google cross ref
  • 25. Bao N, Ochir S, Sun Z, Borjihan G, Yamagishi T 2014 Occurrence of piperidine alkaloids in piper species collected in different areas [J Nat Med] Vol.68 P.211-214 google cross ref
  • 26. Barrajon-Catalan E, Herranz-Lopez M, Joven J, Segura-Carretero A, Alonso-Villaverde C, Menendez JA, Micol V 2014 Molecular promiscuity of plant polyphenols in the management of age-related diseases: Far beyond their antioxidant properties [Adv Exp Med Biol] Vol.824 P.141-159 google
  • 27. Baty V, Mougin B, Dekeuwer C, Carret G 2014 Gut health in the era of the human gut microbiota: From metaphor to biovalue [Med Health Care Philos] Vol.17 P.579-597 google cross ref
  • 28. Belapurkar P, Goyal P, Tiwari-Barua P 2014 Immunomodulatory effects of triphala and its individual constituents: A review [Indian J Pharm Sci] Vol.76 P.467-475 google
  • 29. Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER, Costa-Lotufo LV 2013 Overview of the therapeutic potential of piplartine (piperlongumine) [Eur J Pharm Sci] Vol.48 P.453-463 google cross ref
  • 30. Bhanumathy M, Shivaprasad HN, Nargund LVG 2013 Protective effect of Curcuma longa rhizomes against physical stressinduced perturbations in rats [J Nat Remedies] Vol.14 P.27-32 google
  • 31. Bharal N, Sahaya K, Jain S, Mediratta PK, Sharma KK 2008 Curcumin has anticonvulsant activity on increasing current electroshock seizures in mice [Phytother Res] Vol.22 P.1660-1664 google cross ref
  • 32. Bhatia N, Jaggi A, Singh N, Anand P, Dhawan R 2011 Adaptogenic potential of curcumin in experimental chronic stress and chronic unpredictable stress-induced memory deficits and alterations in functional homeostasis [J Nat Med] Vol.65 P.532-543 google cross ref
  • 33. Biradar YS, Jagatap S, Khandelwal KR, Singhania SS 2008 Exploring of antimicrobial activity of triphala mashi-an ayurvedic formulation [Evid Based Complement Alternat Med] Vol.5 P.107-113 google cross ref
  • 34. Birringer M 2011 Hormetics: Dietary triggers of an adaptive stress response [Pharm Res] Vol.28 P.2680-2694 google cross ref
  • 35. Bolca S, Van de Wiele T, Possemiers S 2013 Gut metabotypes govern health effects of dietary polyphenols [Curr Opin Biotechnol] Vol.24 P.220-225 google cross ref
  • 36. Bradford PG 2013 Curcumin and obesity [Biofactors] Vol.39 P.78-87 google cross ref
  • 37. Brahma Naidu P, Nemani H, Meriga B, Mehar SK, Potana S, Ramgopalrao S 2014 Mitigating efficacy of piperine in the physiological derangements of high fat diet induced obesity in sprague dawley rats [Chem Biol Interact] Vol.221 P.42-51 google cross ref
  • 38. Brekhman II, Dardymov IV 1969 New substances of plant origin which increase nonspecific resistance [Annu Rev Pharmacol] Vol.9 P.419-430 google cross ref
  • 39. Brindley DN, Rolland Y 1989 Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis [Clin Sci (Lond)] Vol.77 P.453-461 google cross ref
  • 40. Brodniewicz T, Grynkiewicz G 2012 Plant phenolics as drug leads - what is missing [Acta Pol Pharm] Vol.69 P.1203-1217 google
  • 41. Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J 2011 Gut microbiota and diabetes: From pathogenesis to therapeutic perspective [Acta Diabetol] Vol.48 P.257-273 google cross ref
  • 42. Calabrese EJ 2010 Hormesis is central to toxicology, pharmacology and risk assessment [Hum Exp Toxicol] Vol.29 P.249-261 google cross ref
  • 43. Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, Cuzzocrea S, Rizzarelli E, Calabrese EJ 2012 Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity [Biochim Biophys Acta] Vol.1822 P.753-783 google cross ref
  • 44. Calabrese V, Cornelius C, Trovato A, Cavallaro M, Mancuso C, Di Rienzo L, Condorelli D, De Lorenzo A, Calabrese EJ 2010 The hormetic role of dietary antioxidants in free radical-related diseases [Curr Pharm Des] Vol.16 P.877-883 google cross ref
  • 45. Carriba P, Comella JX 2014 Amyloid beta, tnfalpha and faim-l; approaching new therapeutic strategies for ad [Front Neurol] Vol.5 P.276 google
  • 46. Cartea ME, Francisco M, Soengas P, Velasco P 2010 Phenolic compounds in brassica vegetables [Molecules] Vol.16 P.251-280 google cross ref
  • 47. Carvalho LA, Urbanova L, Hamer M, Hackett RA, Lazzarino AI, Steptoe A 2015 Blunted glucocorticoid and mineralocorticoid sensitivity to stress in people with diabetes [Psychoneuroendocrinology] Vol.51 P.209-218 google cross ref
  • 48. Chainani-Wu N 2003 Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa) [J Altern Complement Med] Vol.9 P.161-168 google cross ref
  • 49. Chandra P, Bajpai V, Srivastva M, Kumar KBR, Kumar B 2014 Metabolic profiling of piper species by direct analysis using real time mass spectrometry combined with principal component analysis [Anal Methods] Vol.6 P.4234-4239 google cross ref
  • 50. Chandrasekaran C, Vijayalakshmi M, Prakash K, Bansal V, Meenakshi J, Amit A 2012 Review article: Herbal approach for obesity management [Am J Plant Sci] Vol.3 P.1003-1014 google cross ref
  • 51. Chang CL, Chen YC, Chen HM, Yang NS, Yang WC 2013 Natural cures for type 1 diabetes: A review of phytochemicals, biological actions, and clinical potential [Curr Med Chem] Vol.20 P.899-907 google
  • 52. Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC 2013 Herbal therapies for type 2 diabetes mellitus: Chemistry, biology, and potential application of selected plants and compounds [Evid Based Complement Alternat Med] Vol.2013 P.378657 google
  • 53. Chatterjee SS, Kumar V 2012 Holistic psychopharmacology and promiscuous plants and principles of ayurveda [Am J Plant Sci] Vol.3 P.1015-1021 google cross ref
  • 54. Chaudhary SA, Gadhvi KV, Chaudhary AB 2010 Comprehensive review on world herb trade and most utilized medicinal plant [Int J Appl Biol Pharm Tech] Vol.1 P.510-517 google
  • 55. Chaurasia A, Das D 2012 From 5th World Ayurveda Congress Bhopal MPID. Pa01.07. Evaluation of anti hyperglycemic potential of Piper longum root (linn.) on alloxan induced diabetic mice [Anc Sci Life] Vol.32 P.S56 google cross ref
  • 56. Chaurasia A, Das D 2013 Evaluation of antihyperglycemic potential of Piper longum root (linn.) on alloxan induced diabetic mice [Adv Pharmacol Toxicol] Vol.14 P.1-6 google
  • 57. Chempakam B, Parthasarathy VA, Parthasarathy VA, Chempakam B, Zachariah TJ 2008 Turmeric P.97-123 google
  • 58. Cherng YG, Tsai CC, Chung HH, Lai YW, Kuo SC, Cheng JT 2013 Antihyperglycemic action of sinapic acid in diabetic rats [J Agric Food Chem] Vol.61 P.12053-12059 google cross ref
  • 59. Chimakurthy J, Talasila M 2010 Effects of curcumin on pentylenetetrazole-induced anxiety-like behaviors and associated changes in cognition and monoamine levels [Psychol Neurosci] Vol.3 P.239-244 google cross ref
  • 60. Chiou YS, Wu JC, Huang Q, Shahidi F, Wang YJ, Ho CT, Pan MH 2014 Metabolic and colonic microbiota transformation may enhance the bioactivities of dietary polyphenols [J Func Foods] Vol.7 P.3-25 google cross ref
  • 61. Choi S, Choi Y, Choi Y, Kim S, Jang J, Park T 2013 Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice [Food Chem] Vol.141 P.3627-3635 google cross ref
  • 62. Choudhary KM, Mishra A, Poroikov VV, Goel RK 2013 Ameliorative effect of curcumin on seizure severity, depression like behavior, learning and memory deficit in postpentylenetetrazole-kindled mice [Eur J Pharmacol] Vol.704 P.33-40 google cross ref
  • 63. Choudhary M, Sangha J, Grover K 2014 Conventional and nonconventional edible oils: An indian perspective [J Am Oil Chemists' Soc] Vol.91 P.179-206 google cross ref
  • 64. Chouhan B, Kumawat RC, Kotecha M, Ramamurthy A, Nathani S 2013 Triphala: A comprehensive ayurvedic review [Int J Res Ayurveda Pharm] Vol.4 P.612-617 google cross ref
  • 65. Chulet R, Pradhan P 2009 A review on rasayana [Pharmacogn Rev] Vol.3 P.229-234 google
  • 66. Cicero Bezerra Felipe F, Trajano Sousa Filho J, de Oliveira Souza LE, Alexandre Silveira J, Esdras de Andrade Uchoa D, Rocha Silveira E, Deusdenia Loiola Pessoa O, de Barros Viana GS 2007 Piplartine, an amide alkaloid from piper tuberculatum, presents anxiolytic and antidepressant effects in mice [Phytomedicine] Vol.14 P.605-612 google cross ref
  • 67. Cnop M, Foufelle F, Velloso LA 2012 Endoplasmic reticulum stress, obesity and diabetes [Trends Mol Med] Vol.18 P.59-68 google cross ref
  • 68. Colagiuri S 2010 Diabesity: Therapeutic options [Diabetes Obes Metab] Vol.12 P.463-473 google cross ref
  • 69. Costantini D, Metcalfe NB, Monaghan P 2010 Ecological processes in a hormetic framework [Ecol Lett] Vol.13 P.1435-1447 google cross ref
  • 70. Cryan JF, Dinan TG 2012 Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour [Nat Rev Neurosci] Vol.13 P.701-712 google cross ref
  • 71. D’Souza JJ, D’Souza PP, Fazal F, Kumar A, Bhat HP, Baliga MS 2014 Anti-diabetic effects of the indian indigenous fruit Emblica officinalis gaertn: Active constituents and modes of action [Food Funct] Vol.5 P.635-644 google cross ref
  • 72. D’Aversa F, Tortora A, Ianiro G, Ponziani F, Annicchiarico B, Gasbarrini A 2013 Gut microbiota and metabolic syndrome [Intern Emerg Med] Vol.8 P.11-15 google cross ref
  • 73. Dai R, Lim LT 2014 Release of allyl isothiocyanate from mustard seed meal powder [J Food Sci] Vol.79 P.E47-53 google cross ref
  • 74. Dallman MF, Pecoraro NC, la Fleur SE 2005 Chronic stress and comfort foods: Self-medication and abdominal obesity [Brain Behav Immun] Vol.19 P.275-280 google cross ref
  • 75. Dasaroju S, Gottumukkala KM 2014 Current trends in the research of Emblica officinalis (amla): A pharmacological perspective [Int J Pharm Sci Rev Res] Vol.24 P.150-159 google
  • 76. Davenport J, Balch M, Galam L, Girgis A, Hall J, Blagg BS, Matts RL 2014 High-throughput screen of natural product libraries for hsp90 inhibitors [Biology (Basel)] Vol.3 P.101-138 google
  • 77. Davinelli S, Sapere N, Zella D, Bracale R, Intrieri M, Scapagnini G 2012 Pleiotropic protective effects of phytochemicals in alzheimer's disease [Oxid Med Cell Longev] Vol.2012 P.386527 google
  • 78. Davis C 2014 Evolutionary and neuropsychological perspectives on addictive behaviors and addictive substances: Relevance to the “food addiction” construct [Subst Abuse Rehabil] Vol.5 P.129-137 google
  • 79. Dembinska-Kiec A, Mykkanen O, Kiec-Wilk B, Mykkanen H 2008 Antioxidant phytochemicals against type 2 diabetes [Br J Nutr] Vol.99 P.ES109-ES11 google
  • 80. Dhanalakshmi S, Devi RS, Srikumar R, Manikandan S, Thangaraj R 2007 Protective effect of triphala on cold stressinduced behavioral and biochemical abnormalities in rats [Yakugaku Zasshi] Vol.127 P.1863-1867 google cross ref
  • 81. Dhanalakshmi S, Srikumar R, Manikandan S, Parthasarathy NJ, Devi RS 2006 Antioxidant property of triphala on cold stress induced oxidative stress in experimental rats [J Health Sci] Vol.52 P.843-847 google cross ref
  • 82. Dietrich MO, Horvath TL 2012 Limitations in anti-obesity drug development: The critical role of hunger-promoting neurons [Nat Rev Drug Discov] Vol.11 P.675-691 google cross ref
  • 83. Dinan TG, Cryan JF 2012 Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinology [Psychoneuroendocrinology] Vol.37 P.1369-1378 google cross ref
  • 84. Dinkova-Kostova AT, Kostov RV 2012 Glucosinolates and isothiocyanates in health and disease [Trends Mol Med] Vol.18 P.337-347 google cross ref
  • 85. Doucette CD, Hilchie AL, Liwski R, Hoskin DW 2013 Piperine, a dietary phytochemical, inhibits angiogenesis [J Nutr Biochem] Vol.24 P.231-239 google cross ref
  • 86. Dragan S, Andrica F, Serban MC, Timar R 2015 Polyphenols-rich natural products for treatment of diabetes [Curr Med Chem] Vol.22 P.14-22 google
  • 87. Drewnowski A, Gomez-Carneros C 2000 Bitter taste, phytonutrients, and the consumer: A review [Am J Clin Nutr] Vol.72 P.1424-1435 google
  • 88. Eddouks M, Bidi A, El Bouhali B, Hajji L, Zeggwagh NA 2014 Antidiabetic plants improving insulin sensitivity [J Pharm Pharmacol] Vol.66 P.1197-1214 google cross ref
  • 89. Epel ES, Lithgow GJ 2014 Stress biology and aging mechanisms: Toward understanding the deep connection between adaptation to stress and longevity [J Gerontol A Biol Sci Med Sci] Vol.69 P.S10-S16 google cross ref
  • 90. Epel ES 2009 Psychological and metabolic stress: A recipe for accelerated cellular aging [Hormones (Athens)] Vol.8 P.7-22 google cross ref
  • 91. Everard A, Cani PD 2013 Diabetes, obesity and gut microbiota [Best Pract Res Clin Gastroenterol] Vol.27 P.73-83 google cross ref
  • 92. Fahey JW, Wade KL, Stephenson KK, Chou FE 2003 Separation and purification of glucosinolates from crude plant homogenates by high-speed counter-current chromatography [J Chromatogr A] Vol.996 P.85-93 google cross ref
  • 93. Farag YM, Gaballa MR 2011 Diabesity: An overview of a rising epidemic [Nephrol Dial Transplant] Vol.26 P.28-35 google cross ref
  • 94. Farooqui AA 2013 Effect of dietary phytochemicals on metabolic syndrome and neurological disorders P.191-234 google
  • 95. Fasinu PS, Bouic PJ, Rosenkranz B 2012 An overview of the evidence and mechanisms of herb-drug interactions [Front Pharmacol] Vol.3 P.69 google
  • 96. Fetrow CW, Avila JR 1999 Professional’s handbook of complementary and alternative medicines google
  • 97. Fontana L 2009 Modulating human aging and age-associated diseases [Biochim Biophys Acta] Vol.1790 P.1133-1138 google cross ref
  • 98. Foster JA, McVey Neufeld KA 2013 Gut-brain axis: How the microbiome influences anxiety and depression [Trends Neurosci] Vol.36 P.305-312 google cross ref
  • 99. Franco R, Cedazo-Minguez A 2014 Successful therapies for alzheimer's disease: Why so many in animal models and none in humans [Front Pharmacol] Vol.5 P.146 google
  • 100. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ 2007 Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an alzheimer mouse model [J Neurochem] Vol.102 P.1095-1104 google cross ref
  • 101. Gastaldi G, Ruiz J 2009 Metabolic dysfunction and chronic stress: A new sight at “diabesity” pandemic [Rev Med Suisse] Vol.5 P.1273-1277 google
  • 102. Ghelardini C, Galeotti N, Di Cesare Mannelli L, Mazzanti G, Bartolini A 2001 Local anaesthetic activity of beta-caryophyllene [Farmaco] Vol.56 P.387-389 google cross ref
  • 103. Gilhotra N, Dhingra D 2014 Possible involvement of gabaergic and nitriergic systems for antianxiety-like activity of piperine in unstressed and stressed mice [Pharmacol Rep] Vol.66 P.885-891 google cross ref
  • 104. Ginty AT, Phillips AC, Higgs S, Heaney JL, Carroll D 2012 Disordered eating behaviour is associated with blunted cortisol and cardiovascular reactions to acute psychological stress [Psychoneuroendocrinology] Vol.37 P.715-724 google cross ref
  • 105. Ginty AT 2013 Blunted responses to stress and reward: Reflections on biological disengagement [Int J Psychophysiol] Vol.90 P.90-94 google cross ref
  • 106. Gonzalez-Castejon M, Rodriguez-Casado A 2011 Dietary phytochemicals and their potential effects on obesity: A review [Pharmacol Res] Vol.64 P.438-455 google cross ref
  • 107. Goodacre R 2007 Metabolomics of a superorganism [J Nutr] Vol.137 P.259S-266S google
  • 108. Greiner AK, Papineni RV, Umar S 2014 Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome [Am J Physiol Gastrointest Liver Physiol] Vol.307 P.G1-15 google cross ref
  • 109. Grover JK, Yadav S, Vats V 2002 Hypoglycemic and antihyperglycemic effect of Brassica juncea diet and their effect on hepatic glycogen content and the key enzymes of carbohydrate metabolism [Mol Cell Biochem] Vol.241 P.95-101 google cross ref
  • 110. Grover JK, Yadav SP, Vats V 2003 Effect of feeding murraya koeingii and Brassica juncea diet on [correction] kidney functions and glucose levels in streptozotocin diabetic mice [J Ethnopharmacol] Vol.85 P.1-5 google cross ref
  • 111. Grynkiewicz G, Slifirski P 2012 Curcumin and curcuminoids in quest for medicinal status [Acta Biochim Pol] Vol.59 P.201-212 google
  • 112. Gunthorpe MJ, Szallasi A 2008 Peripheral trpv1 receptors as targets for drug development: New molecules and mechanisms [Curr Pharm Des] Vol.14 P.32-41 google cross ref
  • 113. Gupta PC 2012 Biological and pharmacological properties of Terminalia chebula retz. (haritaki)-an overview [Int J Pharm Pharm Sci] Vol.4 P.62-68 google
  • 114. Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB 2013 Multitargeting by turmeric, the golden spice: From kitchen to clinic [Mol Nutr Food Res] Vol.57 P.1510-1528 google cross ref
  • 115. Halkier BA, Gershenzon J 2006 Biology and biochemistry of glucosinolates [Annu Rev Plant Biol] Vol.57 P.303-333 google cross ref
  • 116. Hasan MN, Ferdoushi A, Ara N, Rahman S, Hossan MS, Rahmatullah M 2014 Preliminary phytochemical screening, toxicity, antihyperglycemic and analgesic activity studies with Curcuma longa leaves [World J Pharm Pharm Sci] Vol.3 P.81-91 google
  • 117. Huang H, Morgan CM, Asolkar RN, Koivunen ME, Marrone PG 2010 Phytotoxicity of sarmentine isolated from long pepper (Piper longum) fruit [J Agric Food Chem] Vol.58 P.9994-10000 google cross ref
  • 118. Inyang IJ, Eyo AAO, Olajide TM, Essien A 2014 Effects of ethanolic extract of Brassica juncea (mustard seed) on the brain and kidney tissues of albino wistar rats [J Biol Agric Healthc] Vol.4 P.75-82 google
  • 119. Jakovljevic T, Cvjetko M, Sedak M, Dokic M, Bilandzic N, Vorkapic-Furac J, Redovnikovic IR 2013 Balance of glucosinolates content under cd stress in two brassica species [Plant Physiol Biochem] Vol.63 P.99-106 google cross ref
  • 120. Janero DR 2014 Relieving the cardiometabolic disease burden: A perspective on phytometabolite functional and chemical annotation for diabetes management [Expert Opin Pharmacother] Vol.15 P.5-10 google cross ref
  • 121. Jayaprakasha GK, Rao LJ, Sakariah KK 2006 Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin [Food Chem] Vol.98 P.720-724 google cross ref
  • 122. Jiang J, Wang W, Sun YJ, Hu M, Li F, Zhu DY 2007 Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage [Eur J Pharmacol] Vol.561 P.54-62 google cross ref
  • 123. Jiang ZY, Liu WF, Huang CG, Huang XZ 2013 New amide alkaloids from Piper longum [Fitoterapia] Vol.84 P.222-226 google cross ref
  • 124. Jin Z, Borjihan G, Zhao R, Sun Z, Hammond GB, Uryu T 2009 Antihyperlipidemic compounds from the fruit of Piper longum L [Phytother Res] Vol.23 P.1194-1196 google cross ref
  • 125. Jo YS, Park JR, Park SK, Chun SS, Chung SY, Ha BS 1993 Effects of mustard leaf (Brassica juncea) on cholesterol metabolism in rats [Korean J Nutr] Vol.26 P.13-20 google
  • 126. Joardar A, Das S 2007 Effect of fatty acids isolated from edible oils like mustard, linseed or coconut on astrocytes maturation [Cell Mol Neurobiol] Vol.27 P.973-983 google cross ref
  • 127. John R, Ahmad P, Gadgil K, Sharma S 2009 Heavy metal toxicity: Effect on plant growth, biochemical parameters and metal accumulation by Brassica juncea L [Int J Plant Prod] Vol.3 P.65-76 google
  • 128. Joshi J, Ghaisas S, Vaidya A, Vaidya R, Kamat DV, Bhagwat AN, Bhide S 2003 Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers [J Assoc Physicians India] Vol.51 P.1055-1060 google
  • 129. Joshi JV, Paradkar PH, Jagtap SS, Agashe SV, Soman G, Vaidya AB 2011 Chemopreventive potential and safety profile of a Curcuma longa extract in women with cervical low-grade squamous intraepithelial neoplasia [Asian Pac J Cancer Prev] Vol.12 P.3305-3311 google
  • 130. Joven J, Rull A, Rodriguez-Gallego E, Camps J, Riera-Borrull M, Hernandez-Aguilera A, Martin-Paredero V, Segura- Carretero A, Micol V, Alonso-Villaverde C, Menendez JA 2013 Multifunctional targets of dietary polyphenols in disease: A case for the chemokine network and energy metabolism [Food Chem Toxicol] Vol.51 P.267-279 google cross ref
  • 131. Jung HA, Woo JJ, Jung MJ, Hwang GS, Choi JS 2009 Kaempferol glycosides with antioxidant activity from Brassica juncea [Arch Pharm Res] Vol.32 P.1379-1384 google cross ref
  • 132. Kadian R, Parle M, Yadav M 2014 Therapeutic potential and phytopharmacology of Terminalia bellerica [World J Pharm Pharm Sci] Vol.3 P.804-819 google
  • 133. Kahn SE, Cooper ME, Del Prato S 2014 Pathophysiology and treatment of type 2 diabetes: Perspectives on the past, present, and future [Lancet] Vol.383 P.1068-1083 google cross ref
  • 134. Kandarkar SV, Sawant SS, Ingle AD, Deshpande SS, Maru GB 1998 Subchronic oral hepatotoxicity of turmeric in mice--histopathological and ultrastructural studies [Indian J Exp Biol] Vol.36 P.675-679 google
  • 135. Kar S, Roy K 2012 Qsar of phytochemicals for the design of better drugs [Expert Opin Drug Discov] Vol.7 P.877-902 google cross ref
  • 136. Karakida F, Ikeya Y, Tsunakawa M, Yamaguchi T, Ikarashi Y, Takeda S, Aburada M 2007 Cerebral protective and cognitionimproving effects of sinapic acid in rodents [Biol Pharm Bull] Vol.30 P.514-519 google cross ref
  • 137. Kasabri V, Flatt PR, Abdel-Wahab YHA 2014 In vitro modulation of pancreatic insulin secretion, extrapancreatic insulin action and peptide glycation by Curcuma longa aqueous extracts [J Exp Integr Med] Vol.4 P.187-193 google
  • 138. Kelly SJ, Ismail M 2015 Stress and type 2 diabetes: A review of how stress contributes to the development of type 2 diabetes [Annu Rev Public Health] Vol.36 P.441-462 google cross ref
  • 139. Kennedy DO 2014 Plants and the human brain google
  • 140. Kennedy DO 2014 Polyphenols and the human brain: Plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefits [Adv Nutr] Vol.5 P.515-533 google cross ref
  • 141. Khadem S, Marles RJ 2010 Monocyclic phenolic acids; hydroxyand polyhydroxybenzoic acids: Occurrence and recent bioactivity studies [Molecules] Vol.15 P.7985-8005 google cross ref
  • 142. Khan BA, Abraham A, Leelamma S 1997 Anti-oxidant effects of curry leaf, murraya koenigii and mustard seeds, Brassicajuncea in rats fed with high fat diet [Indian J Exp Biol] Vol.35 P.148-150 google
  • 143. Khan BA, Abraham A, Leelamma S 1995 Hypoglycemic action of murraya koenigii (curry leaf) and Brassica juncea (mustard): Mechanism of action [Indian J Biochem Biophys] Vol.32 P.106-108 google
  • 144. Khan BA, Abraham A, Leelamma S 1996 Murraya koenigii andBrassica juncea-alterations on lipid profile in 1-2 dimethyl hydrazine induced colon carcinogenesis [Invest New Drugs] Vol.14 P.365-369 google
  • 145. Khosla S, Sharma S 2012 A short description on pharmacogenetic properties of Emblica officinalis [Spatula DD] Vol.2 P.187-193 google cross ref
  • 146. Kiasalari Z, Roghani M, Khalili M, Rahmati B, Baluchnejadmojarad T 2013 Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy [Pharm Biol] Vol.51 P.1572-1578 google cross ref
  • 147. Kim DSHL, Park S-Y, Kim J-Y 2001 Curcuminoids from Curcuma longa l. (zingiberaceae) that protect pc12 rat pheochromocytoma and normal human umbilical vein endothelial cells from βa(1?142) insult [Neurosci Lett] Vol.303 P.57-61 google cross ref
  • 148. Kim HY, Yokozawa T, Cho EJ, Cheigh HS, Choi JS, Chung HY 2003 In vitro and in vivo antioxidant effects of mustard leaf (Brassica juncea) [Phytother Res] Vol.17 P.465-471 google cross ref
  • 149. Kim JE, Jung MJ, Jung HA, Woo JJ, Cheigh HS, Chung HY, Choi JS 2002 A new kaempferol 7-o-triglucoside from the leaves of Brassica juncea L [Arch Pharm Res] Vol.25 P.621-624 google cross ref
  • 150. Kokate CK, Purohit AP, Gokhale SB 2003 Practical Pharmacognosy google
  • 151. Krishna M, Joy B, Sundaresan A 2014 Effect on oxidative stress, glucose uptake level and lipid droplet content by apigenin 7, 4'-dimethyl ether isolated from Piper longum L [J Food Sci Tech] P.1-10 google
  • 152. Krishnaveni M, Mirunalini S 2010 Therapeutic potential of Phyllanthus emblica (amla): The ayurvedic wonder [J Basic Clin Physiol Pharmacol] Vol.21 P.93-105 google
  • 153. Ku SK, Kim JA, Bae JS 2014 Vascular barrier protective effects of piperlonguminine in vitro and in vivo [Inflamm Res] Vol.63 P.369-379 google cross ref
  • 154. Kulkarni S, Dhir A, Akula KK 2009 Potentials of curcumin as an antidepressant [ScientificWorldJournal] Vol.9 P.1233-1241 google cross ref
  • 155. Kumar A, Panghal S, Mallapur SS, Kumar M, Ram V, Singh BK 2009 Antiinflammatory activity of Piper longum fruit oil [Indian J Pharm Sci] Vol.71 P.454-456 google cross ref
  • 156. Kumar S, Andy A 2012 Health promoting bioactive phytochemicals from brassica [Int Food Res J] Vol.19 P.141-152 google
  • 157. Kumar S, Kamboj J, Sharma S 2011 Overview for various aspects of the health benefits of Piper longum Linn [J Acupunct Meridian Stud] Vol.4 P.134-140 google cross ref
  • 158. Kumar S, Sharma S, Vasudeva N 2013 Screening of antidiabetic and antihyperlipidemic potential of oil from Piper longum and piperine with their possible mechanism [Expert Opin Pharmacother] Vol.14 P.1723-1736 google cross ref
  • 159. Kumar V, Chatterjee SS 2014 A holistic approach for evaluating the potential of triphala extract against neurological disorders [PharmaNutrition] Vol.2 P.90 google
  • 160. Kumar V, Chatterjee SS 2014 Single and repeated dose effects of phytochemicals in rodent behavioural models [EC Pharm Sci] Vol.1 P.16-18 google
  • 161. Kumar V, Thakur A, Chatterjee S, Shankar S, Srivastava RK 2012 Obesity, cancer and psychopathology: Can vegetarian diet be of help? In Nutrition, diet and cancer P.459-491 google
  • 162. Kumar V, Thakur AK, Barothia ND, Chatterjee SS 2011 Therapeutic potentials of Brassica juncea: An overview [TANG (Humanitas Medicine)] Vol.1 P.1-17 google
  • 163. Kumudhavalli MV, Mohit V, Jayakar B 2010 Phytochemical and pharmacological evaluation of the plant fruit of Terminalia belerica roxb [Int J Pharm Life Sci] Vol.1 P.1-11 google
  • 164. Kuo CC, Moon K, Thayer KA, Navas-Acien A 2013 Environmental chemicals and type 2 diabetes: An updated systematic review of the epidemiologic evidence [Curr Diab Rep] Vol.13 P.831-849 google cross ref
  • 165. Kuo CP, Lu CH, Wen LL, Cherng CH, Wong CS, Borel CO, Ju DT, Chen CM, Wu CT 2011 Neuroprotective effect of curcumin in an experimental rat model of subarachnoid hemorrhage [Anesthesiology] Vol.115 P.1229-1238 google
  • 166. Kuroda M, Mimaki Y, Nishiyama T, Mae T, Kishida H, Tsukagawa M, Takahashi K, Kawada T, Nakagawa K, Kitahara M 2005 Hypoglycemic effects of turmeric (Curcuma longa l. Rhizomes) on genetically diabetic kk-ay mice [Biol Pharm Bull] Vol.28 P.937-939 google cross ref
  • 167. Kwon DY, Kim HJ, Yoon SH, Hou CT, Shaw JF 2009 Induction of phenolics and terpenoids in edible plants using plant stress responses P.249-258 google
  • 168. Langstieh AJ, Verma P, Thakur AK, Chatterjee SS, Kumar V 2014 Desensitization of mild stress triggered responses in mice by a Brassica juncea Leaf extract and some ubiquitous secondary plant metabolites [Pharmacologia] Vol.5 P.326-338 google cross ref
  • 169. Lao CD, Ruffin MTt, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, renner DE 2006 Dose escalation of a curcuminoid formulation [BMC Complement Altern Med] Vol.6 P.10 google cross ref
  • 170. Le Bourg E, Rattan SI 2014 Hormesis and trade-offs: A comment [Dose Response] Vol.12 P.522-524 google cross ref
  • 171. Lee HE, Kim DH, Park SJ, Kim JM, Lee YW, Jung JM, Lee CH, Hong JG, Liu X, Cai M, Park KJ, Jang DS, Ryu JH 2012 Neuroprotective effect of sinapic acid in a mouse model of amyloid beta(1-42) protein-induced alzheimer’s disease [Pharmacol Biochem Behav] Vol.103 P.260-266 google cross ref
  • 172. Lee J, Jo DG, Park D, Chung HY, Mattson MP 2014 Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: Focus on the nervous system [Pharmacol Rev] Vol.66 P.815-868 google cross ref
  • 173. Lee SA, Hwang JS, Han XH, Lee C, Lee MH, Choe SG, Hong SS, Lee D, Lee MK, Hwang BY 2008 Methylpiperate derivatives from Piper longum and their inhibition of monoamine oxidase [Arch Pharm Res] Vol.31 P.679-683 google cross ref
  • 174. Lee SW, Rho MC, Park HR, Choi JH, Kang JY, Lee JW, Kim K, Lee HS, Kim YK 2006 Inhibition of diacylglycerol acyltransferase by alkamides isolated from the fruits of Piper longum and piper nigrum [J Agric Food Chem] Vol.54 P.9759-9763 google cross ref
  • 175. Leiherer A, Mundlein A, Drexel H 2013 Phytochemicals and their impact on adipose tissue inflammation and diabetes [Vascul Pharmacol] Vol.58 P.3-20 google cross ref
  • 176. Lekshmi PC, Arimboor R, Indulekha PS, Menon AN 2012 Turmeric (Curcuma longa l.) volatile oil inhibits key enzymes linked to type 2 diabetes [Int J Food Sci Nutr] Vol.63 P.832-834 google cross ref
  • 177. Lephart ED, Farooqui T, Farooqui AA 2015 Polyphenols and cognitive function P.143-161 google
  • 178. Li J, Ho C-T, Li HE, Tao H, Tao L 2000 Separation of sterols and triterpene alcohols from unsaponifiable fractions of three plant seed oils [J Food Lipids] Vol.7 P.11-20 google cross ref
  • 179. Li S, Wang C, Li W, Koike K, Nikaido T, Wang MW 2007 Antidepressant-like effects of piperine and its derivative, antiepilepsirine [J Asian Nat Prod Res] Vol.9 P.421-430 google cross ref
  • 180. Li S, Wang C, Wang M, Li W, Matsumoto K, Tang Y 2007 Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms [Life Sci] Vol.80 P.1373-1381 google cross ref
  • 181. Li S, Yuan W, Deng G, Wang P, Yang P, Aggarwal BB 2011 Chemical composition and product quality control of turmeric (Curcuma longa L.) [Phytochemistry] Vol.2 P.28-54 google
  • 182. Liju VB, Jeena K, Kuttan R 2013 Acute and subchronic toxicity as well as mutagenic evaluation of essential oil from turmeric (Curcuma longa L) [Food Chem Toxicol] Vol.53 P.52-61 google cross ref
  • 183. Liju VB, Jeena K, Kuttan R 2011 An evaluation of antioxidant, antiinflammatory, and antinociceptive activities of essential oil from Curcuma longa. L [Indian J Pharmacol] Vol.4 P.526-531 google
  • 184. Lin Y, Sun Z 2010 Current views on type 2 diabetes [J Endocrinol] Vol.204 P.1-11 google cross ref
  • 185. Liu J-Y, Chen X-X, Tang SC-W, Lao L-X, Cho-Wing Sze S, Lee K-F, Zhang KY-B 2015 Edible plants from traditional chinese medicine is a promising alternative for the management of diabetic nephropathy [J Func Foods] Vol.14 P.12-22 google cross ref
  • 186. Liu Z, Yu Y, Li X, Ross CA, Smith WW 2011 Curcumin protects against a53t alpha-synuclein-induced toxicity in a pc12 inducible cell model for parkinsonism [Pharmacol Res] Vol.63 P.439-444 google cross ref
  • 187. Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD 2014 Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study [J Affect Disord] Vol.167 P.368-375 google cross ref
  • 188. Lushchak VI 2014 Dissection of the hormetic curve: Analysis of components and mechanisms [Dose Response] Vol.12 P.466-479 google cross ref
  • 189. Lushchak VI 2014 Hormesis in biology and pharmacology [Biochem Pharmacol] Vol.3 P.1-2 google
  • 190. Madhu K, Chanda K, Saji MJ 2013 Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: A randomized placebo-controlled trial [Inflammopharmacology] Vol.21 P.129-136 google cross ref
  • 191. Maheshwari M 2010 Comparative bioavailability of curcumin, turmeric and biocurcumaxTM in traditional vehicles using noneverted rat intestinal sac model [J Func Foods] Vol.2 P.60-65 google cross ref
  • 192. Maheshwari RK, Rajnee K 2014 Ingenious triphala: A curative preparation for health care [Asian J Chem Pharm Res] Vol.2 P.175-185 google
  • 193. Manach C, Hubert J, Llorach R, Scalbert A 2009 The complex links between dietary phytochemicals and human health deciphered by metabolomics [Mol Nutr Food Res] Vol.53 P.1303-1315 google cross ref
  • 194. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L 2004 Polyphenols: Food sources and bioavailability [Am J Clin Nutr] Vol.79 P.727-747 google
  • 195. Maneesa P, Scholfield CN, Chootip K 2012 Piperine is antihyperlipidemic and improves endothelium-dependent vasorelaxation in rats on a high cholesterol diet [J Physiol Biomed Sci] Vol.25 P.27-30 google
  • 196. Manesh C, Kuttan G 2003 Anti-tumour and anti-oxidant activity of naturally occurring isothiocyanates [J Exp Clin Cancer Res] Vol.22 P.193-199 google
  • 197. Manohar PR, Pushpan R, Rohini S 2009 Mustard and its uses in ayurveda [Indian J Tradit Knowl] Vol.8 P.400-404 google
  • 198. Manoj P, Soniya EV, Banerjee NS, Ravichandran P 2004 Recent studies on well-known spice, Piper longum Linn [Nat Prod Radiance] Vol.3 P.222-227 google
  • 199. Mao QQ, Huang Z, Zhong XM, Xian YF, Ip SP 2014 Brain-derived neurotrophic factor signalling mediates the antidepressant-like effect of piperine in chronically stressed mice [Behav Brain Res] Vol.261 P.140-145 google cross ref
  • 200. Martinez JA, Milagro FI 2015 Genetics of weight loss: A basis for personalized obesity management [Trends Food Sci Tech] Vol.42 P.97-115 google cross ref
  • 201. Martinez JA, Navas-Carretero S, Saris WH, Astrup A 2014 Personalized weight loss strategies-the role of macronutrient distribution [Nat Rev Endocrinol] Vol.10 P.749-760 google cross ref
  • 202. Mayer EA 2011 Gut feelings: The emerging biology of gut-brain communication [Nat Rev Neurosci] Vol.12 P.453-466 google
  • 203. McClure CD, Zhong W, Hunt VL, Chapman FM, Hill FV, Priest NK 2014 Hormesis results in trade-offs with immunity [Evolution] Vol.68 P.2225-2233 google
  • 204. McFadden RMT, Larmonier CB, Midura-Kiela MT, Ramalingam R, Harrison CA, Besselsen DG, Chase J, Caporaso G, Ghishan FK, Kiela PR 2014 The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention [Gastroenterology] Vol.146 P.S66 google
  • 205. McNamara FN, Randall A, Gunthorpe MJ 2005 Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (trpv1) [Br J Pharmacol] Vol.144 P.781-790 google cross ref
  • 206. Meghwal M, Goswami TK 2013 Piper nigrum and piperine: An update [Phytother Res] Vol.27 P.1121-1130 google cross ref
  • 207. Meule A, Heckel D, Jurowich CF, Vogele C, Kubler A 2014 Correlates of food addiction in obese individuals seeking bariatric surgery [Clin Obes] Vol.4 P.228-236 google
  • 208. Micucci M, Aldini R, Cevenini M, Colliva C, Spinozzi S, Roda G, Montagnani M, Camborata C, Camarda L, Chiarini A, Mazzella G, Budriesi R 2013 Curcuma longa l. As a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse [PLoS One] Vol.8 P.e80925 google cross ref
  • 209. Mirmiran P, Bahadoran Z, Azizi F 2014 Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review [World J Diabetes] Vol.5 P.267-281 google cross ref
  • 210. Mishra S, Manchanda SC 2012 Cooking oils for heart health [J Prev Cardiol] Vol.1 P.123-131 google
  • 211. Mohammad K, Larijani B 2013 A systematic review of the antioxidant, anti-diabetic, and anti-obesity effects and safety of triphala herbal formulation [J Med Plants Res] Vol.7 P.831-844 google
  • 212. Moloney RD, Desbonnet L, Clarke G, Dinan TG, Cryan JF 2014 The microbiome: Stress, health and disease [Mamm Genome] Vol.25 P.49-74 google cross ref
  • 213. Mori A, Kabuto H, Pei YQ 1985 Effects of piperine on convulsions and on brain serotonin and catecholamine levels in e1 mice [Neurochem Res] Vol.10 P.1269-1275 google cross ref
  • 214. Munday R, Munday CM 2002 Selective induction of phase ii enzymes in the urinary bladder of rats by allyl isothiocyanate, a compound derived from brassica vegetables [Nutr Cancer] Vol.44 P.52-59 google cross ref
  • 215. Murray S, Kroll C, Avena NM 2015 Food and addiction among the ageing population [Ageing Res Rev] Vol.20 P.79-85 google cross ref
  • 216. Murthy KRS 2009 Bhava prakasha of bhavamisra-english translation google
  • 217. Muttepawar SS, Jadhav SB, Kankudate AD, Sanghai SD, Usturge DR, Chavare SS 2014 A review on bioavailability enhancers of herbal origin [World J Pharm Pharm Sci] Vol.3 P.667-677 google
  • 218. Nabi SA, Kasetti RB, Sirasanagandla S, Tilak TK, Kumar MV, Rao CA 2013 Antidiabetic and antihyperlipidemic activity of Piper longum root aqueous extract in STZ induced diabetic rats [BMC Complement Altern Med] Vol.13 P.37 google cross ref
  • 219. Nariya MB, Shukla VJ, Ravishankar B, Jain SM 2011 Comparison of gastroprotective effects of triphala formulations on stressinduced ulcer in rats [Indian J Pharm Sci] Vol.73 P.682-687 google cross ref
  • 220. Neerati P, Ravi Karan M, Kanwar JR 2012 Influence of curcumin on pioglitazone metabolism and pk/pd: Diabetes mellitus [J Diabetes Metab] Vol.S6 P.1-6 google
  • 221. Neha J, Mishra RN 2011 Adaptogenic activity of Trikatu megaExt [Int J Res Pharm Biomed Sci] Vol.2 P.570-574 google
  • 222. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S 2012 Host-gut microbiota metabolic interactions [Science] Vol.336 P.1262-1267 google cross ref
  • 223. Niciforovic N, Abramovic H 2014 Sinapic acid and its derivatives: Natural sources and bioactivity [Compr Rev Food Sci Food Saf] Vol.13 P.34-51 google cross ref
  • 224. Noble T, Zingg JM, Paul L, Smith D, Meydani M 2013 The effect of curcumin plus piperine on body weight and fat loss as well as on the plasma levels of inflammatory cytokines in obese mice [FASEB J] Vol.27 P.636 google
  • 225. Nowak D, Dietrich-Muszalska A, Chauhan V, Grignon S 2015 Antioxidant plant polyphenols and cognitive disorders. In Studies on psychiatric disorders P.521-552 google
  • 226. Nyanginja RA, Mponda J 2014 Nutrigenomic approach in understanding the antiallergic effects of curcumin [Asian J Biomed Pharma Sci] Vol.4 P.1-5 google
  • 227. Ono K, Hasegawa K, Naiki H, Yamada M 2004 Curcumin has potent anti-amyloidogenic effects for alzheimer’s beta-amyloid fibrils in vitro [J Neurosci Res] Vol.75 P.742-750 google cross ref
  • 228. Oram RN, Kirk JTO, Veness PE, Hurlstone CJ, Edlington JP, Halsall DM 2005 Breeding indian mustard [Brassica juncea (L.) czern.] for cold-pressed, edible oil production-a review [Australian J Agric Res] Vol.56 P.581-596 google cross ref
  • 229. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS 2004 Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes [Science] Vol.306 P.457-461 google cross ref
  • 230. Pa J, Gazzaley A 2014 Flavanol-rich food for thought [Nat Neurosci] Vol.17 P.1624-1625 google cross ref
  • 231. Pal A, Nayak S, Sahu PK, Swain T 2011 Piperine protects epilepsy associated depression: A study on role of monoamines [Eur Rev Med Pharmacol Sci] Vol.15 P.1288-1295 google
  • 232. Pal US, Khan K, Sahoo NR, Sahoo G 2008 Development and evaluation of farm level turmeric processing equipment [AMA] Vol.39 P.46-50 google
  • 233. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV 1997 Effects of diet and exercise in preventing niddm in people with impaired glucose tolerance. The da qing igt and diabetes study [Diabetes Care] Vol.20 P.537-544 google cross ref
  • 234. Pandey KB, Rizvi SI 2009 Plant polyphenols as dietary antioxidants in human health and disease [Oxid Med Cell Longev] Vol.2 P.270-278 google cross ref
  • 235. Parrott MD, Winocur G, Bazinet RP, Ma DW, Greenwood CE 2015 Whole-food diet worsened cognitive dysfunction in an alzheimer's disease mouse model [Neurobiol Aging] Vol.36 P.90-99 google cross ref
  • 236. Patel D, Patel K, Gadewar M, Tahilyani V 2012 A concise report on pharmacological and bioanalytical aspect of sinigrin [Asian Pac J Trop Biomed] Vol.2 P.S446-S448 google
  • 237. Patel JA, Shah US 2009 Hepatoprotective activity of Piper longum traditional milk extract on carbon tetrachloride induced liver toxicity in wistar rats [Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas] Vol.8 P.121-129 google
  • 238. Patel P, Gohil KJ, Roy SP, Patel N 2014 Investigation of antidepressant and anxiolytic activity of curcumin given alone and in combination with amitriptyline in rats [Indian J Res Pharm Biotechnol] Vol.2 P.1173-1178 google
  • 239. Pathak N, Khandelwal S 2009 Immunomodulatory role of piperine in cadmium induced thymic atrophy and splenomegaly in mice [Environ Toxicol Pharmacol] Vol.28 P.52-60 google cross ref
  • 240. Pati S, Hussain M, Swain S 2014 Characteristics and correlates of diabesity in india: A secondary data analysis of world health survey [Obes Rev] Vol.15 P.67-68 google cross ref
  • 241. Patil UK, Singh A, Chakraborty AK 2011 Role of piperine as a bioavailability enhancer [Int J Recent Adv Pharm Res] Vol.4 P.16-23 google
  • 242. Patrone C, Eriksson O, Lindholm D 2014 Diabetes drugs and neurological disorders: New views and therapeutic possibilities [Lancet Diabetes Endocrinol] Vol.2 P.256-262 google cross ref
  • 243. Pedram P, Sun G 2015 Hormonal and dietary characteristics in obese human subjects with and without food addiction [Nutrients] Vol.7 P.223-238 google
  • 244. Peng D, Xin L, Hao-jie L, Wei-feng P, Jian-ying L, Yu M, Wei F, Xin W 2009 Curcumin inhibits amygdaloid kindled seizures in rats [Chin Med J] Vol.122 P.1435-1438 google
  • 245. Perez-Tilve D, Davidson WS, Tschop M, Hofmann SM 2012 Cns regulation of plasma cholesterol [Ann Med] Vol.44 P.656-663 google cross ref
  • 246. Podar D, Ramsey MH, Hutchings MJ 2004 Effect of cadmium, zinc and substrate heterogeneity on yield, shoot metal concentration and metal uptake by Brassica juncea: Implications for human health risk assessment and phytoremediation [New Phytologist] Vol.163 P.313-324 google cross ref
  • 247. Ponnusamy S, Zinjarde S, Bhargava S, Kumar AR 2012 Role of Curcuma longa, a traditional ayurvedic medicinal plant, in diabetes [TANG (Humanitas Medicine)] Vol.2 P.5-11 google
  • 248. Ponnusankar S, Pandit S, Babu R, Bandyopadhyay A, Mukherjee PK 2011 Cytochrome p450 inhibitory potential of triphala-a rasayana from ayurveda [J Ethnopharmacol] Vol.133 P.120-125 google cross ref
  • 249. Pratley RE, Matfin G 2007 Pre­1diabetes: Clinical relevance and therapeutic approach [Br J Diabetes Vasc Dis] Vol.7 P.120-129 google cross ref
  • 250. Priyadarsini KI 2014 The chemistry of curcumin: From extraction to therapeutic agent [Molecules] Vol.19 P.20091-20112 google cross ref
  • 251. Puranik A, Nabar N, Joshi J, Amonkar A, Shah S, Menon S, Vaidya R, Vaidya ADB 2014 Single dose metformin kinetics after co-administration of nisha-amalaki powder or mamejwa ghanavati, ayurvedic anti-diabetic formulations: A randomized crossover study in healthy volunteers [J Obes Metab Res] Vol.1 P.99-104 google cross ref
  • 252. Qin XY, Cheng Y, Yu LC 2010 Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons [Neurosci Lett] Vol.480 P.21-24 google cross ref
  • 253. Qureshi S, Shah AH, Ageel AM 1992 Toxicity studies on alpinia galanga and Curcuma longa [Planta Med] Vol.58 P.124-127 google cross ref
  • 254. Rajan SS, Antony S 2008 Hypoglycemic effect of triphala on selected non insulin dependent diabetes mellitus subjects [Anc Sci Life] Vol.27 P.45-49 google
  • 255. Rajeswary H, Vasuki R, Samudram P, Geetha A 2011 Hepatoprotective action of ethanolic extracts of melia azedarach linn. And Piper longum Linn and their combination on ccl4 induced hepatotoxicity in rats [Indian J Exp Biol] Vol.49 P.276-281 google
  • 256. Rajopadhye AA, Namjoshi TP, Upadhye AS 2012 Rapid validated hptlc method for estimation of piperine and piperlongumine in root of Piper longum extract and its commercial formulation [Revista Brasileira de Farmacognosia] Vol.22 P.1355-1361 google cross ref
  • 257. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian Diabetes, Prevention P 2006 The indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in asian indian subjects with impaired glucose tolerance (idpp-1) [Diabetologia] Vol.49 P.289-297 google cross ref
  • 258. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A 2012 Trends in prevalence of diabetes in asian countries [World J Diabetes] Vol.3 P.110-117 google cross ref
  • 259. Rao G, Bhat S, Rao GS, Bhat GP 2013 Antidiabetic and antioxidant efficacy of a powdered mixture of Curcuma longa and Emblica officinalis in diabetic rats in comparison with glyburide [WebmedCentral Diabetes] Vol.4 P.1-13 google
  • 260. Rastogi RP, Mehrotra BN 1995 Compendium of Indian medicinal plants google
  • 261. Rastogi S 2014 Ayurvedic science of food and nutrition google
  • 262. Rastogi T, Reddy KS, Vaz M, Spiegelman D, Prabhakaran D, Willett WC, Stampfer MJ, Ascherio A 2004 Diet and risk of ischemic heart disease in india [Am J Clin Nutr] Vol.79 P.582-592 google
  • 263. Rathinamoorthy R, Thilagavathi G 2014 Terminalia chebula-review on pharmacological and biochemical studies [Int J PharmTech Res] Vol.6 P.97-116 google
  • 264. Rauniyar BK, Shakya A, Thakur AK, Chatterjee SS, Kumar V 2015 Anti-stress activity of phloroglucinol: A transient metabolite of some plant polyphenolics [Pharmacologia] Vol.6 P.21-30 google cross ref
  • 265. Rege NN, Thatte UM, Dahanukar SA 1999 Adaptogenic properties of six rasayana herbs used in ayurvedic medicine [Phytother Res] Vol.13 P.275-291 google cross ref
  • 266. Rhee SH, Pothoulakis C, Mayer EA 2009 Principles and clinical implications of the brain-gut-enteric microbiota axis [Nat Rev Gastroenterol Hepatol] Vol.6 P.306-314 google cross ref
  • 267. Rinki S, Mishra RN 2011 Adaptogenic activity of triphala megaext [Int J Res Pharm Biomed Sci] Vol.2 P.579-582 google
  • 268. Rios MY, Olivo HF, Atta ur R 2014 Chapter 3 - natural and synthetic alkamides: Applications in pain therapy P.79-121 google
  • 269. Roy SJ, Stanely Mainzen Prince P 2012 Protective effects of sinapic acid on lysosomal dysfunction in isoproterenol induced myocardial infarcted rats [Food Chem Toxicol] Vol.50 P.3984-3989 google cross ref
  • 270. Ruden D, Lu X 2011 Personalized nutrigenomics: Tailoring the diet to the aging diabesity population [Nutr Diet Suppl] Vol.3 P.31-41 google
  • 271. Sahebkar A 2013 Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome [Biofactors] Vol.39 P.197-208 google cross ref
  • 272. Saleem A, Husheem M, Harkonen P, Pihlaja K 2002 Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. Fruit [J Ethnopharmacol] Vol.81 P.327-336 google cross ref
  • 273. Samudram P, Vasuki R., Rajeshwari H., Geetha A., Moorthi P.S 2009 Antioxidant and antihepatotoxic activities of ethanolic crude extract of melia azedarach and Piper longum [J Med Plants Res] Vol.3 P.1078-1083 google
  • 274. Sandoval DA, Obici S, Seeley RJ 2009 Targeting the cns to treat type 2 diabetes [Nat Rev Drug Discov] Vol.8 P.386-398 google cross ref
  • 275. Sang JP, Minchinton IR, Johnstone PK, Truscott RJ 1984 Glucosinolates profiles in the seed, root and leaf tissue of cabbage, mustard, rapeseed, radish and swede [Can J Plant Sci] Vol.64 P.77-93 google cross ref
  • 276. Sanmukhani J, Anovadiya A, Tripathi CB 2011 Evaluation of antidepressant like activity of curcumin and its combination with fluoxetine and imipramine: An acute and chronic study [Acta Pol Pharm] Vol.68 P.769-775 google
  • 277. Santilli F, Guagnano MT, Vazzana N, La Barba S, Davi G 2015 Oxidative stress drivers and modulators in obesity and cardiovascular disease: From biomarkers to therapeutic approach [Curr Med Chem] Vol.22 P.582-595 google cross ref
  • 278. Sarma GK, Kalita P, Barthakur M, Sarma RK 2014 Importance of traditionally used medicinal plants: Emblica officinalis (L), Curcuma longa (L) & Syzygium cumini (L) in the management of diabetes mellitus [Int Ayurvedic Med J] Vol.2 P.356-361 google
  • 279. Sauer FD, Kramer JKG, Kramer JKG, Sauer FD, Pigden WJ 1983 The problems associated with the feeding of high erucic acid rapeseed oils and some fish oils to experimental animals. In High and low erucic acid rapeseed oils production, usage, chemistry, and toxicological examination P.253-n292 google
  • 280. Saxena V, Mishra G, Vishwakarma KK, Saxena A 2013 A comparative study on quantitative estimation of tannins in Terminalia chebula, Terminalia belerica, Terminalia arjuna and saraca indica using spectrophotometer [Asian J Pharm Clin Res] Vol.6 P.1-2 google
  • 281. Scapagnini G, Davinelli S, Kaneko T, Koverech G, Koverech A, Calabrese EJ, Calabrese V 2014 Dose response biology of resveratrol in obesity [J Cell Commun Signal] Vol.8 P.385-391 google cross ref
  • 282. Schreiner M, Krumbein A, Ruppel S 2009 Interaction between plants and bacteria: Glucosinolates and phyllospheric colonization of cruciferous vegetables by enterobacter radicincitans dsm 16656 [J Mol Microbiol Biotechnol] Vol.17 P.124-135 google cross ref
  • 283. Scott C, Johnstone AM 2012 Stress and eating behaviour: Implications for obesity [Obes Facts] Vol.5 P.277-287 google cross ref
  • 284. Serrano J, Puupponen-Pimia R, Dauer A, Aura AM, Saura-Calixto F 2009 Tannins: Current knowledge of food sources, intake, bioavailability and biological effects [Mol Nutr Food Res] Vol.53 P.S310-329 google cross ref
  • 285. Shakya A, Chatterjee SS, Kumar V 2015 Role of fumarates in adaptogenics like efficacies of traditionally used fumaria indica extracts [TANG (Humanitas Medicine)] Vol.5 P.28-37 google
  • 286. Sharma H, Chandola HM 2011 Prameha in ayurveda: Correlation with obesity, metabolic syndrome, and diabetes mellitus. Part 1-etiology, classification, and pathogenesis [J Altern Complement Med] Vol.17 P.491-496 google cross ref
  • 287. Sharma H, Chandola HM 2011 Prameha in ayurveda: Correlation with obesity, metabolic syndrome, and diabetes mellitus. Part 2-management of prameha [J Altern Complement Med] Vol.17 P.589-599 google cross ref
  • 288. Shin DS, Kim KW, Chung HY, Yoon S, Moon JO 2013 Effect of sinapic acid against dimethylnitrosamine-induced hepatic fibrosis in rats [Arch Pharm Res] Vol.36 P.608-618 google cross ref
  • 289. Shin HJ, Lee JY, Son E, Lee DH, Kim HJ, Kang SS, Cho GJ, Choi WS, Roh GS 2007 Curcumin attenuates the kainic acidinduced hippocampal cell death in the mice [Neuroscience Letters] Vol.416 P.49-54 google cross ref
  • 290. Shivavedi N, Chatterjee SS, Kumar V 2014 Evaluation of pharmacologically interesting dose range of ascorbic acid in mice [SAJ Neurol] Vol.1 P.101 google
  • 291. Shivavedi N, Chatterjee SS, Kumar V 2014 Stress response modulating effects of lactic acid in mice [Ther Targets Neurol Dis] Vol.1 P.e418 google
  • 292. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS 1998 Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers [Planta Med] Vol.64 P.353-356 google cross ref
  • 293. Sims EA, Danforthm E, Jr. Horton ES, Bray GA, Glennon JA, Salans LB 1973 Endocrine and metabolic effects of experimental obesity in man [Recent Prog Horm Res] Vol.29 P.457-496 google
  • 294. Sindhu S, Maya P, Indira TN 2012 A method for preparation of mustard (Brassica juncea) powder with retained pungency and reduced bitterness [LWT - Food Sci Tech] Vol.49 P.42-47 google
  • 295. Singh J, Sharma PC, Sharma SK, Kumar A 2013 Standardization of the fourier transform near-infrared reflectance spectroscopy for estimation of some oil quality parameters in mustard (brassica spp.) [Plant Soil Environ] Vol.59 P.478-483 google
  • 296. Singh K, Shakya R, Mahawar R 2014 Genetic diversity and patterns of variation among Indian mustard (Brassica juncea (l.) czernj. & cosson) varieties [SABRAO J Breed Genet] Vol.46 P.329-339 google
  • 297. Singh N, Kumar S, Singh P, Raj HG, Prasad AK, Parmar VS, Ghosh B 2008 Extract inhibits tnf-alphainduced expression of cell adhesion molecules by inhibiting nfkappab activation and microsomal lipid peroxidation [Phytomedicine] Vol.15 P.284-291 google cross ref
  • 298. Singh R, Arif T, Khan I, Sharma P 2014 Phytochemicals in antidiabetic drug discovery [J Biomed Ther Sci] Vol.1 P.1-33 google
  • 299. Sinha R, Jastreboff AM 2013 Stress as a common risk factor for obesity and addiction [Biol Psychiatry] Vol.73 P.827-835 google cross ref
  • 300. Soni KB, Rajan A, Kuttan R 1992 Reversal of aflatoxin induced liver damage by turmeric and curcumin [Cancer Lett] Vol.66 P.115-121 google cross ref
  • 301. Speciale A, Chirafisi J, Saija A, Cimino F 2011 Nutritional antioxidants and adaptive cell responses: An update [Curr Mol Med] Vol.11 P.770-789 google cross ref
  • 302. Sri KS, Kumari DJ, Sivannarayana G 2013 Effect of amla, an approach towards the control of diabetes mellitus [Int J Curr Microbiol Appl Sci] Vol.2 P.103-108 google
  • 303. Srikumar R, Parthasarathy NJ, Manikandan S, Narayanan GS, Sheeladevi R 2006 Effect of triphala on oxidative stress and on cellmediated immune response against noise stress in rats [Mol Cell Biochem] Vol.28 P.67-74 google
  • 304. Steptoe A, Hackett RA, Lazzarino AI, Bostock S, La Marca R, Carvalho LA, Hamer M 2014 Disruption of multisystem responses to stress in type 2 diabetes: Investigating the dynamics of allostatic load [Proc Natl Acad Sci U S A] Vol.111 P.15693-15698 google cross ref
  • 305. Sunila ES, Kuttan G 2004 Immunomodulatory and antitumor activity of Piper longum Linn. And piperine [J Ethnopharmacol] Vol.90 P.339-346 google cross ref
  • 306. Suri A, Szallasi A 2008 The emerging role of trpv1 in diabetes and obesity [Trends Pharmacol Sci] Vol.29 P.29-36 google cross ref
  • 307. Szallasi A 2005 Piperine: Researchers discover new flavor in an ancient spice [Trends Pharmacol Sci] Vol.26 P.437-439 google
  • 308. Tarozzi A, Angeloni C, Malaguti M, Morroni F, Hrelia S, Hrelia P 2013 Sulforaphane as a potential protective phytochemical against neurodegenerative diseases [Oxid Med Cell Longev] Vol.2013 P.415078 google
  • 309. Tatiraju DV, Bagade VB, Karambelkar PJ, Jadhav VM, Kadam V 2013 Natural bioenhancers: An overview [J Pharmacogn Phytochem] Vol.2 P.55-60 google
  • 310. Thakur AK, Chatterjee SS, Kumar V 2014 Antidepressant-like effects of Brassica juncea L. Leaves in diabetic rodents [Indian J Exp Biol] Vol.52 P.613-622 google
  • 311. Thakur AK, Chatterjee SS, Kumar V 2013 Anxiolytic-like activity of leaf extract of traditionally used Indian-mustard (Brassica juncea) in diabetic rats [TANG (Humanitas Medicine)] Vol.3 P.1-7 google
  • 312. Thakur AK, Chatterjee SS, Kumar V 2013 Beneficial effects of Brassica juncea on cognitive functions in rats [Pharm Biol] Vol.51 P.1304-1310 google cross ref
  • 313. Thakur AK, Shakya A, Husain GM, Emerald M, Kumar V 2014 Gut-microbiota and mental health: Current and future perspectives [J Pharmacol Clin Toxicol] Vol.2 P.1016.1-1016.15 google
  • 314. Thiyagarajan M, Sharma SS 2004 Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats [Life Sci] Vol.74 P.969-985 google cross ref
  • 315. Thomas M, Sujatha KS, George S 2009 Protective effect of Piper longum Linn. On monosodium glutamate induced oxidative stress in rats [Indian J Exp Biol] Vol.47 P.186-192 google
  • 316. Tiwari AK, Rao JM 2002 Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects [Curr Sci] Vol.83 P.30-38 google
  • 317. Tiwari AK 2008 Invigorated barley in diabetes [Curr Sci] Vol.95 P.25-29 google
  • 318. Tomas-Menor L, Barrajon-Catalan E, Segura-Carretero A, Marti N, Saura D, Menendez JA, Joven J, Micol V 2015 The promiscuous and synergic molecular interaction of polyphenols in bactericidal activity: An opportunity to improve the performance of antibiotics [Phytother Res] Vol.29 P.466-473 google cross ref
  • 319. Triggle DJ 2012 Nous sommes tous des bacteries: Implications for medicine, pharmacology and public health [Biochem Pharmacol] Vol.84 P.1543-1550 google cross ref
  • 320. Tripathi MK, Mishra AS 2007 Glucosinolates in animal nutrition: a review [Anim Feed Sci Tech] Vol.132 P.1-27 google cross ref
  • 321. Tripathi S, Raghuram N, Ramarao NH 2012 Validation of an integrated ayurveda-yoga module for residential treatment of patients with type 2 diabetes mellitus - a compilation from traditional literature [Int J Ayurvedic Herbal Med] Vol.2 P.921-934 google
  • 322. Trowbridge A, Monson RK 2014 The evolutionary ecology of chemically mediated plant-insect interactions P.1-29 google
  • 323. Tschop MH, DiMarchi RD 2012 Outstanding scientific achievement award lecture 2011: Defeating diabesity: The case for personalized combinatorial therapies [Diabetes] Vol.61 P.1309-1314 google cross ref
  • 324. Ulbricht C, Basch E, Barrette E-P, Boon H, Chao W, Costa D, Higdon ERB, Isaac R, Lynch M, Papaliodis G, Grimes Serrano JM, Varghese M, Vora M, Windsor R, Woods J 2011 Turmeric (Curcuma longa): An evidence-based systematic review by the natural standard research collaboration [Altern Complement Ther] Vol.17 P.225-236 google
  • 325. Vaghasiya Y, Nair R, Chanda S 2007 Investigation of piper species for antibacterial and anti-inflammatory property [Int J Pharmacol] Vol.3 P.400-405 google cross ref
  • 326. Vaibhavi B, Satyam T, Sanjibkumar P, Raghuram N, Ramarao NH 2013 Effect of holistic module of yoga and ayurvedic panchakarma in type 2 diabetes mellitus-a pilot study [Open J Endocr Metab Dis] Vol.3 P.90-98 google cross ref
  • 327. Vaidya AD 2014 Metabolic management: The role of nutraceuticals, nutritionals and naturals [J Obes Metab Res] Vol.1 P.79-82 google cross ref
  • 328. Vaiserman AM 2014 Aging-modulating treatments: From reductionism to a system-oriented perspective [Front Genet] Vol.5 P.446 google
  • 329. van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJ, Gross G, Roger LC, Possemiers S, Smilde AK, Dore J, Westerhuis JA, Van de Wiele T 2011 Metabolic fate of polyphenols in the human superorganism [Proc Natl Acad Sci USA] Vol.108 P.4531-4538 google cross ref
  • 330. van Ommen B, Stierum R 2002 Nutrigenomics: Exploiting systems biology in the nutrition and health arena [Curr Opin Biotechnol] Vol.13 P.517-521 google cross ref
  • 331. Vedhanayaki G, Shastri GV, Kuruvilla A 2003 Analgesic activity of Piper longum Linn. Root [Indian J Exp Biol] Vol.41 P.649-651 google
  • 332. elusami CC, Boddapati SR, Hongasandra Srinivasa S, Richard EJ, Joseph JA, Balasubramanian M, Agarwal A 2013 Safety evaluation of turmeric polysaccharide extract: Assessment of mutagenicity and acute oral toxicity [Biomed Res Int] Vol.2013 P.158348 google
  • 333. Venkateshwarlu G, Venkata NCH, Shantha TR, Kishore KR, Prathapa RM, Raghavendra HL 2013 A comparative physicochemical and pharmacognostical evaluation of nishamalaki- an ayurvedic antidiabetic formulation [Sci Tech Arts Res J] Vol.2 P.69-78 google
  • 334. Verma S, Chatterjee SS, Kumar V 2014 Comparative adaptogenic activity of bioavailable extracts of Curcuma longa and pure curcumin in rodents (NEU-22) [Indian J Pharmacol] Vol.46 P.S93-S94 google
  • 335. Verma S, Chatterjee SS, Kumar V 2015 Metformin like stress response modulating effects of turmeric curcuminoids in mice [SAJ Neurol] Vol.1 P.102 google
  • 336. Wakade AS, Shah AS, Kulkarni MP, Juvekar AR 2008 Protective effect of Piper longum L. On oxidative stress induced injury and cellular abnormality in adriamycin induced cardiotoxicity in rats [Indian J Exp Biol] Vol.46 P.528-533 google
  • 337. Walia H, Arora S 2013 Terminalia chebula- a pharmacognistic account [J Med Plants Res] Vol.7 P.1351-1361 google
  • 338. Wang HH, Hsieh HL, Wu CY, Sun CC, Yang CM 2009 Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and jnk-dependent ap-1 pathway in brain astrocytes [Glia] Vol.57 P.24-38 google cross ref
  • 339. Wang MS, Boddapati S, Emadi S, Sierks MR 2010 Curcumin reduces alpha-synuclein induced cytotoxicity in parkinson’s disease cell model [BMC Neurosci] Vol.11 P.57 google cross ref
  • 340. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL 2014 Novel insights of dietary polyphenols and obesity [J Nutr Biochem] Vol.25 P.1-18 google cross ref
  • 341. Wang Y, Tang H, Kochhar S, Martin F-P 2015 Roles of herbal medicine in modulating gut microbiota associated with health and diseases P.185-197 google
  • 342. Wendlinger C, Hammann S, Vetter W 2014 Various concentrations of erucic acid in mustard oil and mustard [Food Chem] Vol.153 P.393-397 google cross ref
  • 343. Winston D, Maimes S 2007 Adaptogens: Herbs for strength, stamina, and stress relief google
  • 344. Wu Y, Min X, Zhuang C, Li J, Yu Z, Dong G, Yao J, Wang S, Liu Y, Wu S, Zhu S, Sheng C, Wei Y, Zhang H, Zhang W, Miao Z 2014 Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents [Eur J Med Chem] Vol.82 P.545-551 google cross ref
  • 345. Xia X, Cheng G, Pan Y, Xia ZH, Kong LD 2007 Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. In the mouse forced swimming test [J Ethnopharmacol] Vol.110 P.356-363 google cross ref
  • 346. Xia X, Pan Y, Ou-Yang Z, Wang J, Pan L-L, Zhu Q, Huang J-J, Kong L-D 2011 Pharmacokinetic-pharmacodynamic modeling of monoamine oxidase a inhibitory activity and behavior improvement by curcumin in the mouse forced swimming test [Chin J Nat Med] Vol.9 P.293-304 google
  • 347. Xia X, Pan Y, Zhang WY, Cheng G, Kong LD 2006 Ethanolic extracts from Curcuma longa attenuates behavioral, immune, and neuroendocrine alterations in a rat chronic mild stress model [Biol Pharm Bull] Vol.29 P.938-944 google cross ref
  • 348. Xiao JB, Hogger P 2015 Dietary polyphenols and type 2 diabetes: Current insights and future perspectives [Curr Med Chem] Vol.22 P.23-38 google
  • 349. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ 2005 Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats [Pharmacol Biochem Behav] Vol.82 P.200-206 google cross ref
  • 350. Yadav SP, Vats V, Ammini AC, Grover JK 2004 Brassica juncea (rai) significantly prevented the development of insulin resistance in rats fed fructose-enriched diet [J Ethnopharmacol] Vol.93 P.113-116 google cross ref
  • 351. Yadav V, Kumar V 2014 Advances in modern knowledge of dravyaguna of Piper longum during last five years (REV-15) [Indian J Pharmacol] Vol.4 P.S109 google
  • 352. Yang C, Zhang X, Fan H, Liu Y 2009 Curcumin upregulates transcription factor nrf2, ho-1 expression and protects rat brains against focal ischemia [Brain Res] Vol.1282 P.133-141 google cross ref
  • 353. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM 2005 Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo [J Biol Chem] Vol.280 P.5892-5901 google cross ref
  • 354. Yang J, Su Y, Luo J-F, Gu W, Niu H-M, Li Y, Wang Y-H, Long C-L 2013 New amide alkaloids from Piper longum fruits [Nat Prod Bioprospect] Vol.3 P.277-281 google cross ref
  • 355. Yang T, Sun S, Wang T, Tong X, Bi J, Wang Y, Sun Z 2014 Piperlonguminine is neuroprotective in experimental rat stroke [Int Immunopharmacol] Vol.23 P.447-451 google cross ref
  • 356. Yokozawa T, Kim HY, Cho EJ, Choi JS, Chung HY 2002 Antioxidant effects of isorhamnetin 3,7-di-o-beta-dglucopyranoside isolated from mustard leaf (Brassica juncea) in rats with streptozotocin-induced diabetes [J Agric Food Chem] Vol.50 P.5490-5495 google cross ref
  • 357. Yokozawa T, Kim HY, Cho EJ, Yamabi N, Choi JS 2003 Protective effects of mustard leaf (Brassica juncea) against diabetic oxidative stress [J Nutr Sci Vitaminol (Tokyo)] Vol.49 P.87-93 google cross ref
  • 358. Yoon BH, Jung JW, Lee JJ, Cho YW, Jang CG, Jin C, Oh TH, Ryu JH 2007 Anxiolytic-like effects of sinapic acid in mice [Life Sci] Vol.81 P.234-240 google cross ref
  • 359. Yu JC, Jiang ZT, Li R, Chan SM 2003 Chemical composition of the essential oils of Brassica juncea (L.) coss. Grown in different regions, hebei, shaanxi and shandong, of china [J Food Drug Anal] Vol.11 P.22-26 google
  • 360. Yu SY, Gao R, Zhang L, Luo J, Jiang H, Wang S 2013 Curcumin ameliorates ethanol-induced memory deficits and enhanced brain nitric oxide synthase activity in mice [Prog Neuropsychopharmacol Biol Psychiatry] Vol.44 P.210-216 google cross ref
  • 361. Yu ZF, Kong LD, Chen Y 2002 Antidepressant activity of aqueous extracts of Curcuma longa in mice [J Ethnopharmacol] Vol.83 P.161-165 google cross ref
  • 362. Zaki M, Begum W, Bhat TA, Kausar H 2014 Amla (Emblica officinalis gaertn) the wonderful unani drug: A review [World J Pharm Pharm Sci] Vol.3 P.1369-1381 google
  • 363. Zaveri M, Khandhar A, Patel S A P 2010 Chemistry and pharmacology of Piper longum L [Int J Pharm Sci Rev Res] Vol.5 P.67-76 google
  • 364. Zhang DW, Fu M, Gao SH, Liu JL 2013 Curcumin and diabetes: A systematic review [Evid Based Complement Alternat Med] P.636053 google
  • 365. Zhang YJ, Abe T, Tanaka T, Yang CR, Kouno I 2001 Phyllanemblinins a-f, new ellagitannins from Phyllanthus emblica [J Nat Prod] Vol.64 P.1527-1532 google cross ref
  • 366. Zhao L, Ackerman SL 2006 Endoplasmic reticulum stress in health and disease [Curr Opin Cell Biol] Vol.18 P.444-452 google cross ref
이미지 / 테이블
  • [ Table 1. ]  Pharmacological activities of diverse types of Brassica juncea extracts suggesting their curative or preventive potentials against diabesity associated comorbidities
    Pharmacological activities of diverse types of Brassica juncea extracts suggesting their curative or preventive potentials against diabesity associated comorbidities
  • [ Table 2. ]  Some major bioactive constituents of Brassica juncea identified to date, and their often-cited pharmacological activities
    Some major bioactive constituents of Brassica juncea identified to date, and their often-cited pharmacological activities
  • [ Table 3. ]  Some reports suggesting therapeutic potentials of Piper longum extracts against diabesity and associated comorbidities
    Some reports suggesting therapeutic potentials of Piper longum extracts against diabesity and associated comorbidities
  • [ Table 4. ]  Major bioactive constituents of Piper longum L. identified to date, and their often-cited pharmacological activities
    Major bioactive constituents of Piper longum L. identified to date, and their often-cited pharmacological activities
  • [ Table 5. ]  Some reported neuro-pharmacological activities of Curcumin and of two other Turmeric curcuminoids
    Some reported neuro-pharmacological activities of Curcumin and of two other Turmeric curcuminoids
  • [ Table 6. ]  Reports suggesting therapeutic potentials of Curcuma longa extracts against diabesity and associated comorbidities
    Reports suggesting therapeutic potentials of Curcuma longa extracts against diabesity and associated comorbidities
(우)06579 서울시 서초구 반포대로 201(반포동)
Tel. 02-537-6389 | Fax. 02-590-0571 | 문의 : oak2014@korea.kr
Copyright(c) National Library of Korea. All rights reserved.